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“Come forth into the light of things, 
let Nature be your teacher”. 
William Wordsworth   
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ApoB      apolipoprotein B 
BMI      body mass index 
CI       confidence interval 
CONOR     Cohort of Norway 
CVD      cardiovascular disease 
CS      cesarean section 
HDL      high density lipoprotein 
IVF       in vitro fertilization 
LDL      low density lipoprotein 
MBRN     Medical Birth Registry of Norway 
OC        oral contraceptive 
OR       odds ratio 
PCOS      polycystic ovary syndrome 
PE       preeclampsia 
PTD      preterm delivery 
RR       relative risk 
SGA      small for gestational age 
TG       triglyceride 
TG/HDL   triglycerides to high density lipoprotein ratio 
TFR      total fertility rate 
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Paper I 
Question: Is there an association between pre-pregnant lipid levels 
and number of children? 
Period: 1994-2003, followed for a 2nd birth until 2008. 
Study population: 2 645 parous women and 1 677 nulliparous 
women participating in Cohort of Norway and with linked data 
from the Medical Birth Registry of Norway  
Exposure: Pre-pregnant lipid levels  
Outcome: Number of born children 
 
Paper II 
Question: What is the status of post-pregnancy lipid levels in one-
child mothers compared to mothers with two or more children? 
Are women’s post-pregnancy lipid levels associated with number 
of children? 
Period: 1994-2003, followed for a 2nd birth until 2008.  
Study population: 32 618 parous women examined after first 
childbirth in Cohort of Norway and with linked data from the 
Medical Birth Registry of Norway 
Exposure: Post-pregnant lipid levels  
Outcome: Number of born children 
 
Paper III 
Question: What is the risk of having one lifetime pregnancy by 
adverse pregnancy outcomes and how does perinatal loss modify 
this risk?  
Period: 1967-2007, followed for a 2nd birth until 2014. 
Study population: 882 803 mothers giving birth to their first 
singleton baby and followed until 2014 in the Medical Birth 
Registry of Norway  
Exposure: Preterm delivery, preeclampsia, small for gestational 
age, cesarean section and perinatal loss 




Background: Cardiovascular disease (CVD) is an important public health problem and 
remains the number one cause of death in women. Substantial increase in CVD mortality has 
been found in women with only one child, and lipid disorders are suggested to play a role in 
both subfertility and later CVD development. 
Objectives: To explore the extent to which pre-pregnant serum lipid levels of total, low 
density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol, triglyceride (TG) 
and triglycerides to high density lipoprotein (TG/HDL) ratio are associated with having no 
and one lifetime pregnancy; to estimate post-pregnancy lipid levels in one-child mothers 
compared to mothers with two or more children and to assess these lipid’s associations with 
number of children; to explore if preterm delivery (PTD), preeclampsia (PE), small for 
gestational age (SGA) and cesarean section (CS) at first birth are associated with having one 
lifetime pregnancy, and assess the modifying effect of perinatal loss. 
Material and Methods: In paper I we analysed prepregnant lipid levels in 2 645 women 
giving birth to their first child during 1994 - 2003 and in 1 677 nulliparous women with 
linked data from Cohort of Norway (CONOR) and The Medical Birth Registry of Norway 
(MBRN).  In paper II we used data on 32 618 parous women examined after first childbirth 
as part of CONOR (1994-2003) with linked data on reproduction and number of children 
from the MBRN (1967-2008). Paper III was a population-based study of 882 803 mothers 
giving birth to their first singleton infant (≥22 gestational weeks) during 1967 to 2007 who 
were followed for the occurrence of second birth in the MBRN until 2014. Logistic 
regression (Papers I and II) and generalized linear models (Paper III) were used to calculate 
odds ratios (ORs) and relative risks (RRs) with 95% confidence intervals (CIs) and to adjust 
for confounders. 
Results:  Assessed in quintiles, higher pre-pregnant TG and TG/HDL ratio levels were 
associated with increased risk of one lifetime pregnancy compared to having ≥ 2 children. 
Compared to the highest quintile, women in the lowest quintile of HDL cholesterol levels 
had an increased risk of one lifetime pregnancy (OR 1.7 95% CI 1.2-2.4), as were women 
with the highest LDL cholesterol, TG and TG/HDL ratio quintiles (compared to the lowest) 




Similar effects were found in women with BMI ≥ 25 and the highest LDL and total 
cholesterol levels in risk of lifetime nulliparity. When examined after first childbirth in paper 
II, ORs for one lifetime pregnancy for the highest quintiles of LDL and total cholesterol 
(compared to lowest quintiles) were 1.30 (95%CI: 1.14-1.45) and 1.43 (95%CI: 1.27-1.61), 
respectively. In women with pregnancy complications where the infant survived the perinatal 
period, RRs for one lifetime pregnancy were increased (PTD: 1.21 [1.19-1.22], SGA: 1.13 
[1.12-1.15], PE: 1.09 [1.07-1.11], CS: 1.24 [1.23-1.25]), but significantly reduced if the child 
was lost (PTD: 0.63 [0.59-0.68], SGA: 0.57 [0.51-0.63], PE: 0.69 [0.59-0.80], CS: 0.67 
[0.56-0.79]), compared to women with no perinatal loss and no adverse outcome. 
Conclusions and implications: Unfavorable pre-pregnant lipid levels were associated 
with having no and one lifetime pregnancy. The association with unfavourable lipids was 
also present for one child mothers with lipids measured more than a decade after childbirth. 
These findings provide a possible biological underpinning for a joint mechanistic pathway 
for reduced fertility and cardiovascular conditions. Associations between adverse outcomes 
of pregnancy and the risk of having one lifetime pregnancy were strongly modified by child 
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Cardiovascular disease (CVD) is an important public health problem and remains the 
number one cause of death in women (1). Although recent Norwegian reports suggest a 
decrease in CVD incidence for men, the decline has been less pronounced for women (2). 
Several Norwegian studies have observed higher CVD mortality among women with 
only one child (3, 4). Relative to mothers of two children, childless women and those 
with one child had higher mortality risks for nearly all causes (5, 6). 
Efforts to elucidate this association are many, but inconclusive, ranging from lifestyle 
risk factors associated with childrearing (7), sex hormone fluctuations (8) and protective 
effect of future pregnancies (8). Considering the increased CVD mortality among women 
with low parity (3, 4, 5, 6, 8), the information about possible underlying biological 
factors adds critical value from a public health perspective. Given the lipid’s role in both 
CVD and female fertility (9, 10, 11) and the lack of lipid-fertility studies in humans, 
increased knowledge of the association between women’s lipid profile and the number of 
children may provide valuable insights for the observed inverse parity-CVD mortality 
association. Apart from specific biologic links, other pathways may also play a role in 
reproductive patterns. As previous pregnancy experience may shape women’s decision 
towards future pregnancies (1, 12), insights into the adverse pregnancy effects on 
women’s future reproduction could add valuable knowledge about reproductive patterns.  
In this thesis, we sought to explore possible biological underpinning for the association 
between low parity and increased CVD mortality as well as to investigate the effect of 











1.1.1 Fertility trends in Norway, Scandinavia and Europe  
In Norway, the total fertility rate (TFR) has over the last 25 years been higher than the 
Nordic average, with only Iceland having a consistently higher TFR than Norway (13). In 
Europe, only France, Ireland and the United Kingdom had higher TFR than Norway in 2013 
(13). Recent data show an overall decline in TFR in Scandinavia, with Iceland, Norway and 
Finland showing record-low TFR, while other European countries have followed the same 
declining trend (14). 
Historically, the decline in fertility in Norway from 2.5 (in women born during the 1930s) to 
the current level has largely been attributed to an increased proportion of women who 
stopped their childbearing after reaching two births (13). A decline in higher order births 
started during the 1960s and lasted for approximately a decade, leading to final stabilization 
(with the exception of a smaller decline in 2000-2002) (13). In Norway, we currently have a 
rather stabile second birth rate, while the major contributors to the fertility decline are 
suggested to be advanced age at first birth and lower third birth rates (15) (Figure 1).  
 
 
Figure 1. Women in selected cohorts of births, by number of children at age 45 
                (x-axis: birth cohorts; y-axis: %) 
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Fertility rates for European countries show a similar decline in TFR from the mid-1960s until 
the turn of the century (14). At the beginning of the 2000s, fertility in most European 
countries displayed signs of rising until 2010. After that, we have had a more or less stabile 
European decline, with more advanced age at first childbirth, similar to the Norwegian trend 




Across Europe, higher order births are less common today with a decrease in the frequency 
of large families (14). Most of the fertility declines are reflected in a drop in the proportion 
of third and higher order births, and an increase in the share of first order births. At the 
European level, almost half of all households with children had only one child (16). As for 
Norway, in 2016 it was most common for children to live with one sibling (46%), while 25% 
lived with two siblings and 8% lived with three or more (17), suggesting a preserved modal 
family size of 2 children.   
 




Globally, the observed drop in TFR from the 1950s onwards might partly reflect societal 
changes that have been widely accepted (13, 18, 19). This includes a shift in women’s social 
roles and consequential larger investments in women’s education (13). Other social changes 
such as a shift from agriculture to urban living may also influence the preferable family size, 
especially in traditional agriculture-oriented regions, with less incentive for families to have 
more kids that could be a helping hand in farm-work (19). In the ongoing debate, several 
points have been suggested as key factors for the globally observed fertility decline: fewer 
deaths in childhood, more women in education and greater access to contraception (18). In 
Norway, decreased fertility has created political concern, facilitated by the most recent 
record low TFR (20). Following the year 2009, reports suggest the impact of economic 
activity, women’s work experience and unemployment in the municipality on both 
postponement of first births and the decrease in higher order births (21). Although second 
order births remain stable (13, 15, 21), for higher order births, economic stability seems to be 
becoming increasingly important (21).  
From the demographic perspective, differences across developed countries are largely driven 
by differences in the probability of having a second child (22). In their attempts to 
investigate demographic, sociological and economic factors that play a role in the decline of 
family size, Lutz and Skirbekk introduced the term “low fertility trap” to describe countries 
where it is common to have few children (mostly < 2) (23).  In its simplified interpretation, 
low fertility hypothesis assumes that after some years of stability, ideal family size may enter 
a period of decline, particularly in those countries that experienced very low actual fertility 
rates (given that preferences can be influenced by the actual fertility) (23).  
 
1.1.2 The effect of adverse pregnancy outcomes on later 
reproduction  
Desired family size is influenced by various factors, both biological and socioeconomic 
(including social norms and related personal choices) (1, 24). It has been shown that 
preexisting poor health can shape women’s decision towards future pregnancies (1, 4, 25), as 
can previous experience of adverse pregnancy outcomes (1, 4). Cesarean section (CS) rates 
are at increase (24, 26), and accompanying adverse pregnancy outcomes such as preterm 
delivery (PTD) and small for gestational age (SGA) continue to be public health challenges, 
despite health system improvements (26). Besides having high co-occurrence and 
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interrelation (26), it is suggested that these outcomes, along with preeclampsia (PE) are 
associated with reduced subsequent fertility (1, 12). The effect of CS is a subject of ongoing 
debate, with implications from some studies that it might pose physical consequences on 
subsequent fertility (27, 28). The association between subfertility and PTD has been 
suggested (29), while the recurrence risk of PTD proposes shared maternal-fetal genetic 
aspects (25, 26). Experience of PE is also found to decrease subsequent reproduction, 
however, whether the effects are due to biological or psychological consequences remains 
inconclusive (30, 31). As for perinatal loss, the inverse effect has been proposed, due to its 
association with increased reproduction (12, 24, 32). In epidemiologic studies, this concept is 
known as ’selective fertility’ and has been described as the tendency to replace losses in 
order to obtain the desired number of children (32, 33). Besides observed increased 
reproduction following the death of an infant, this is further supported by decreased 
reproduction after twin pregnancies (32). Failure to consider this factor in epidemiologic 
studies when estimating the effects of pregnancy outcomes on future reproduction may lead 
to erroneous conclusions (33). 
Psychological effect. Childbirth represents one of the milestones in women’s life and can 
have a profound effect on women’s psychosocial well being (34, 35). Previous traumatic 
birth experience can, therefore, make woman reluctant to conceive again (1, 4, 25, 35, 36). 
Fear of childbirth is one of the suggested reasons for avoiding future pregnancies after 
operative delivery (34). Aligned with this are studies that report reduced subsequent birth 
rate after CS (35, 37, 38). A study on traumatic birth experience suggested that younger 
women (<35 years of age) and partnered primiparas who rated their first birth experience as 
negative were less likely to have a subsequent birth compared with women who rated their 
experience as average or good (39). In contrast, a Swedish study on 451 primiparous women 
found that perceived negative birth experience, mode of delivery and adverse pregnancy 
outcomes were not significantly associated with not having another child (40). The authors 
attributed such finding to the context of childbirth in Sweden, where women and their 
partners can talk through their experience with a health care provider in case of an adverse 
event during the pregnancy or childbirth (40). A more extreme level of fear – tocophobia – 
has been defined as ‘severe fear of childbirth’ (36), and has variable prevalence rates 
(ranging 6 -14%), mostly due to lack of consensus on the definition of tocophobia (34, 35). 




by women who were not aware of the body’s natural ability to cope with childbirth, 
suggesting the importance of informativeness of women prior to labour (41).  
 
1.1.3 Why Norway is an optimal setting for exploring low parity  
As opposed to a large number of European countries that were being caught in the “low-
fertility trap”, Norway has for years kept its modal family size (2 children) on Nordic 
average (13). The embeddedness of fertility decisions in social contexts has already been 
recognized in a study of German fertility (42), while a Finnish study suggested that ‘cultural 
normative’ factors account for relatively high levels of higher order births in local social 
contexts (43). Kravdal describes several factors as a reason for stabile modal family size in 
Norway in comparison to most other rich countries (13): 
1. Norway’s advantaged economic position. Norwegian per capita gross domestic 
product is one of the highest in the world, which allowed the creation of a low-risk 
social environment concerning income, unemployment and social support. In 
addition, Norway has a low income inequality, where very few are considered poor 
with low trends of unemployment. This advantaged economic position allowed the 
government’s generous policies and welfare arrangements, leading to low income 
insecurity for individual families and state support for parental leave. This has also 
shown its effect after the International Financial Crisis (2008), enabling Norway to 
contain the impact of the crisis, leading to quite milder recession compared to other 
European countries (44). Furthermore, widely spread social liberal ideas about gender 
equality and public responsibility for individual well-being, which are found to 
positively affect fertility, have strong roots in all the Nordic countries.  
2. Flexible higher education system that allows students to leave and later re-enter 
schooling, with readily available educational loans and student daycare. Largely free 
high quality tertiary education along with paid parental leave tends to lower social 
pressure to restrict childbearing, which allows women in Norway to raise a family 
without compromising education and/or career.  
3. While the retreat from marriage as a traditional family unit has been pronounced as 
in most rich countries, in Norway this has been largely replaced by cohabitation. The 
relatively high fertility among cohabiting couples might reflect the strong trust in the 
welfare state and liberal values. It is also possible that factors that might discourage 
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reproduction among cohabitants tend to be weaker in Norway than in many other 
countries.  
Given that norms to some extent reflect current actual behaviour, higher fertility level in 
Norway compared to the European average tends to further promote high fertility (13). 
Aligned with this, despite the corresponding increase in the mean age of mothers with 
second births, there have been no observed significant change in second birth rates (21). This 
implicates that most women who become mothers in Norway, will continue their 
reproduction beyond one child (21). Similarly, in his demographic research in European 
countries (45), Frejka suggests that it is more common for women with one child to have a 
second child in Norway than in most other rich countries.  
 
1.1.4 The higher CVD mortality of one-child mothers 
Pregnancy exerts complex physiological influences on the female cardiovascular system and 
other organ systems. Such influences are fluctuations of serum sex hormones, hemodynamic 
changes, oxidative stress and changes in lipid and other blood profiles (1). It has become 
apparent that the event of pregnancy per se and women’s overall reproductive patterns may 
have long-term implications for future health. The association between a number of children 
(parity) and CVD mortality (and/or morbidity) came into focus during the 1980s and 1990s, 
leading to one of the first important insights in this field (46). The majority (8, 47, 48, 49), 
but not all (50, 51) of the following epidemiological studies have reported a J-shaped 
association between parity and CVD mortality, showing the highest risk among nulliparous 
women and one-child mothers (with nadir of risk in 2 births). In agreement with this, several 
population-based Norwegian studies found that mortality for late middle-aged women was 
highest for the childless and mothers with one child (3, 4, 5, 6), with particularly excess 
CVD mortality among one-child mothers (up to 50%) (4, 5). A recent dose-response meta-
analysis of cohort-studies confirmed a non-linear J-shaped association between parity 
number and CVD risk and reported a 4% increased risk of CVD in women with one lifetime 
birth (49). Efforts to elucidate the association between the number of children and the risk of 
female CVD have been inconclusive (1, 8). Explanations range from biological to social, and 
include: lifestyle risk factors associated with childrearing (7), sex hormone fluctuations, 
protective effect of future pregnancies (8), and lifestyle factors prior to conception such as 




gestation (1). Biological condition as a possible explanation for the observed parity-
CVD/mortality association was offered by early studies (53, 54) when different patterns of 
fertility were reported to be related to changes in post-pregnancy blood lipids and blood 
pressure levels. It is, however, still unclear if the biological factors are present in women 
with low parity (one-child mothers) before they conceive.  
 
1.1.5 CVD in women 
Historically, cardiovascular disease (CVD) was widely perceived as a public health problem 
for the male population (55). This was mostly due to the fact that women develop coronary 
heart disease about a decade later than men, while for myocardial infarction the occurrence is 
around 10-15 years later (56). The situation, however, reverses itself once women develop 
the disease. Case-fatality rates are higher for women, following both myocardial infarction 
and myocardial revascularization procedures: 23% of women and 18% of men die of a heart 
attack within one year after the event (55). Although death rates from CVD are declining, 
still more women die of CVD (1, 2). A recent Norwegian publication reported significant 
declines in the incidence of acute myocardial infarction across all age groups for men, while 
less steep decline in women is observed, significant only for the older population (above age 
65) (2). 
Only more recently have we begun to look more into similarities and differences between 
men and women concerning the structure and function of the cardiovascular system. The 
beginning of the research in this field dates from the late 1980s with the observation from 
Steingart’s group (57) that women with symptoms suggestive of coronary artery disease 
were treated less aggressively than man. One reason for this could be that the majority of 
human data originated from studies of young (18-22 years), healthy, 70kg Caucasian males 
(58). While the data undoubtedly enabled increased knowledge of cardiovascular physiology, 
the information has been used to represent the behaviour of humans as a collective, rather 
than a selective (58). Even though the cardiovascular systems of males and females possess 
the same structural elements, how those component function to achieve homeostasis differs 




Sexual dimorphism of cardiac function 
There are clear sex specific differences in the cardiac chamber and coronary artery size, 
which are suggested to be largely (but not completely) explained by body size differences 
(59). Sex differences in the composition of the circulating blood have long been a known 
factor in clinical studies, with the most obvious being a lower number of red blood cells per 
plasma unit volume, and lower plasma protein levels in females than in males (58). Serum 
lipid levels also demonstrate sexual dimorphism, with high density lipoprotein (HDL) 
cholesterol and triglycerides (TGs) being lower in premenopausal woman than in men of the 
same age (58). Although this ‘antiatherogenic’ lipid profile was found to be associated with a 
lower incidence of CVD in these women (compared to the men of the same age), pro-
atherogenic changes after menopause reverse the situation: lipid profile of women becomes 
correlated with a higher incidence of CVD (60). Total cholesterol levels increase with age in 
both sexes, however, the increase for men plateaus around age 45-50, while for women the 
increase continues sharply until age 60-65 (61).  
Hormonal milieu plays an important role in sex specific differences in the cardiovascular 
system (62, 63). Not only that it modulates functional characteristics of the cardiovascular 
system (62), but it is suggested to be the reason for a lower likelihood of coronary artery 
disease in premenopausal women compared to their male counterparts (62). It is well 
established that estrogen exhibits immediate (non-genomic) effects (at the cell membrane 
level), as well as more delayed (genomic) effects (interaction through estrogen receptors at 
the cell nucleus level) (63). Among its known effects is regulation of vasomotoricity 
(stimulating production of vasodilatator nitrous oxide) and protective effects again vascular 
injury (reendothelialization of injured vessels) (64). Estrogen receptors are found both in the 
smooth muscle cells of the coronary arteries (65) and in endothelial cells (66), therefore it 
can increase nitrous oxide production by endothelial cells, inhibit their apoptosis (67) and 
promote their angiogenic activity (65). Estrogen shows an antiatherogenic effect on serum 
lipids: it raises levels of HDL and lowers total cholesterol, low density lipoprotein (LDL) 
and lipoprotein A levels. (68). Accordingly, menopausal transition imposes increased 
vulnerability for the women’s cardiovascular system, as all the protective effects of estrogen 




1.1.6 Lipids and fertility, the role and potential mechanisms 
While the role of serum lipids in cardiovascular health is well established, showing low HDL 
and high TGs and LDL to be strong predictors of CVD (9),  their role in reproduction is 
uncertain. It is, however, well established that both HDL and LDL deliver cholesterol to the 
corpus luteum for progesterone synthesis (69). The presence of HDL cholesterol and ApoB 
in follicular fluid from human oocytes, suggests that these lipids play a more direct role in 
reproduction (10, 11, 70). Studies have identified these lipid fragments in the follicular fluid 
as predictors of embryo quality (71) and have reported appreciably higher clinical pregnancy 
rate and the number of top-quality embryos in high ApoB patients undergoing fertility 
treatment, compared with low ApoB patients, even after exclusion of ovarian-related 
disorders (10).  In addition, higher HDL levels with large and medium particle size 
subfractions were associated with poorer embryo quality, while smaller particle size, with 
more potent antioxidant activity, showed to be beneficial for good embryo quality during 
IVF (71). Fujimoto et al suggest that there is “evidence that the preimplantation embryo does 
not have active cholesterol biosynthesis capacity due to a lack of hydroxymethylglutaryl co-
enzyme A reductase activity until the blastocyst stage. Thus, the cholesterol required for 
early embryo development appears to be solely reliant on the intracellular cholesterol levels 
present in the oocyte prior to fertilization” (69). Previous animal studies have reported the 
association between dyslipidemia and infertility showing sterility in HDL receptor-deficient 
female mice (72) while the Longitudinal Investigation of Fertility and the Environment study 
(LIFE) found concentrations of free cholesterol to be associated with human fecundity in 
both sexes (73). Posed explanations have been that abnormalities in HDL metabolism 
including change in structure, concentration or function compromise female fertility (10, 11, 
70).  It has been suggested that genetic polymorphisms that alter function in proteins 
engaged in cholesterol metabolism may affect human fertility (74, 75). One possible 
molecular mechanism could be through a mediating role of HDL on Paraoxonase 1 (PON1) 
activity. Paraoxonase (PON) is an HDL-associated enzyme that inhibits LDL oxidation, and 
thus protects cells from oxidative stress (76). Its stability and binding affinity are strongly 
influenced by changes in the shape and size of HDL particles (77).  These changes may lead 
to decreased antioxidative capacity and consecutively – oxidative stress. Oxidative stress is 
associated with adverse cardiovascular and fertility outcomes, including atherosclerosis, 
polycystic ovary syndrome (PCOS), PE, endometriosis and infertility (75, 78). A recent 
study in women of reproductive age with upper normal ranges of thyroid-stimulating 
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hormone has suggested a direct link between unfavourable lipid profile and increased 
oxidative membrane damage (79). 
Alterations in serum metabolites may, therefore, be reflected in the oocyte and embryo 
quality (69). It is suggested that a better understanding of the metabolic effects of various 
subfertility etiologies may help improve the likelihood of pregnancy (80). Recently, 
triglycerides to high density lipoprotein (TG/HDL) ratio has been proposed as a simple and 
reliable marker of insulin resistance given that increased serum TGs and low serum HDL 
levels often accompany metabolic syndrome (81). Beyond fertility implications, evidence 
demonstrates that determining the plasma concentration ratio of TG/HDL identifies a subset 
of apparently healthy individuals who display a cardio-metabolic risk profile that predisposes 
to CVD (81). 
 
1.1.7 Reproductive health – underused opportunity to improve 
women’s health 
Pregnancy imposes great alterations in almost every organ of the women’s body, to meet the 
demands of a growing fetus (82). This is accompanied by physiological metabolic and lipid 
alterations, reflecting the maternal metabolic response to support fetal growth (82, 83), with 
accompanying significant hemodynamic changes (84).  These changes impose particularly 
great demands on the cardiovascular system, kidneys and the liver (84). Pregnancy may, 
therefore, act as a stress test (84, 85, 86) revealing vulnerable organ or the system that fails to 
adequately adapt its function during pregnancy (82). This has become apparent in women 
who conceive with chronic conditions (82), and also have implications for assessing 
common pregnancy complications as a possible indicator of subsequent CVD (86). Of 
relevance from the aspect of public health, pregnancy can also act to unmask subclinical 
conditions (or genetic predisposition) in apparently healthy women, which may be 
exaggerated in later life, when the effects of ageing and/or menopausal transition diminish 
the reserves of an impaired organ (system) (82). Recent joint recommendation from the 
American Heart Association and the American College of Obstetricians and Gynecologists 
highlights the importance of utilization of women’s reproductive history as a significant tool 
and additional source of information to optimize early identification and risk assessment for 
CVD (86). Aligned with these guidelines, the American College of Obstetricians and 




the fields of obstetrics, maternal–fetal medicine, hypertension, internal medicine, 
nephrology, anesthesiology, physiology, and patient advocacy) provided additional 
recommendations suggesting regular yearly check-ups of CVD health and related blood 




The overall aim of this thesis was to explore pre- and post-pregnant lipid levels and 
adverse pregnancy outcomes and their association with the probability of having no and 
only one lifetime pregnancy.  
 
The specific aims were: 
To explore the extent to which pre-pregnant serum lipid levels of total, LDL and 
HDL cholesterol, TG and TG/HDL ratio are associated with having no and one 
lifetime pregnancy (Paper I).  
 
To estimate post-pregnant lipid levels in one-child mothers compared to mothers 
with two or more children and to assess these lipid’s associations with the number of 
children. (Paper II). 
 
To explore if PTD, PE, SGA and CS at first birth are associated with having one 





3. Material and Methods 
An overview of material and methods is outlined in Table 1, below. 

















































































































Table 1. Overview of material and methods in the thesis 
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3.1 Data sources 
The current thesis was based on two main population-based data sources: the Cohort of 
Norway (CONOR) and the Medical Birth Registry of Norway (MBRN). We also had 
data on the level of educational attainment from the National Education Database that 
was used in paper III. All Norwegian residents receive a unique national identification 
number that enables linkage of these resources. 
3.1.1 Cohort of Norway  
CONOR is a population-based collection of health data and blood samples provided by 
participators older than 20 years of age residing in several different regions in Norway 
during 1994 to 2003, and obtained through several large health surveys (88).  
Participants were invited to the surveys based on the 11-digit personal identification 
number and addresses obtained from the Population Registry of Norway (88, 89). Data 
collection followed a standard procedure. Letters of invitation were sent approximately 2 
weeks before the time of appointment and included a questionnaire, and information 
about the aims of the study, examinations and procedures. At the examination, the 
questionnaire was collected from the attendees along with their written consent, and 
participants underwent a physical examination and a non-fasting blood sample was 
drawn. The examinations included standardized measurements of height, weight, systolic 
and diastolic blood pressure and non-fasting lipid levels (total cholesterol, HDL 
cholesterol, TGs). Trained personnel conducted all procedures (88). 
The questionnaire consisted of about 50 questions that addressed a wide range of topics: 
self-reported health and disease including diabetes, asthma, coronary heart disease, 
stroke, family history of the disease, risk factors and lifestyle, social network and 
support, education, use of medications and reproductive history (88). 
The administrative responsibility for CONOR was delegated to the Norwegian Institute 
of Public Health (NIPH) in 2002 and is research collaboration between the NIPH and the 





3.1.2 The Medical Birth Registry of Norway 
The MBRN is a population based database with a compulsory notification of all births 
(stillbirths and livebirths) from 16th  week of gestation since 1967 (88). As part of the 
preventive health program of pregnancy in Norway, all women are examined and 
interviewed free of charge by a midwife and/or a general practitioner on a regular basis 
throughout pregnancy. Information on demographic characteristics, medical history, 
body measures, previous births and previous and current complications and interventions 
during delivery were collected. The obtained information was regularly updated in the 
antenatal chart during health visits. At the time of delivery, the antenatal chart is brought 
to the delivery department and all compulsory data were collected by the attending 
physician or midwife and transferred to the MBRN (88). Information about the infant 
(vital status, time of death, anthropometric measurements, Apgar scores and neonatal 
diagnoses) are also collected. The notification of perinatal death specifies the time of 
death and gestational age, and for stillbirths specifies the time of death in relation to 
labour (antepartum, intrapartum or unknown). Gestational age was estimated by last 
menstrual period until 1998, and on ultrasound estimates thereafter. Ultrasound estimates 
that are used originate usually from a routine scan in the second trimester. If the 
information on ultrasound is missing, gestational age estimates are based on the last 
menstrual period. Detailed data on in-vitro fertilization (IVF) were available from 1988 
and were reported from all fertility clinics in the country. As from 1999, the MBRN 
notification form was extended and revised to include additional information about the 
mother, the infant and place of birth. Until 1999 maternal health and all outcomes were 
notified as a free text and coded at the MBRN using ICD-8. As from 1999, checkboxes 
for the most common maternal and infant risk factors were introduced, as well as for 
maternal previous health status. Checkboxes are suggested to contribute to more valid 
information to registries than written text (90).  
The main maternal and fetal complications are notified by checkboxes, in addition to 
available free text in the notification form. This includes PE, CS, and perinatal death. PE 
is reported by checking one or two of the checkboxes (preeclampsia mild; preeclampsia, 
severe; preeclampsia, before 34 weeks) (before 1999, PE was notified as either 
’preeclampsia’ or the combination of ’hypertension’ and ’proteinuria’) (91). Available 
checkboxes also include: HELLP syndrome, eclampsia, gestational hypertension 
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(without proteinuria), and gestational diabetes. Checkboxes for CS include options for 
planned, emergency and unspecified cesarean section.  
Maternal health is reported by checking one of the following options: asthma, allergy, 
recurrent urinary infection, chronic renal disease, chronic hypertension, cardiovascular 
disease, rheumatoid arthritis, epilepsy, diabetes mellitus (type 1, type 2) and other. 
Validation studies have shown a very good ascertainment of pre-gestational diabetes (92) 
and that most women labelled with gestational hypertension in the MBRN have 
hypertensive disorders of pregnancy (93). PE registration in MBRN (91) along with other 
disease and pregnancy complications have shown acceptable accuracy (93), however, the 
possibility of underreporting of milder forms of disease and diabetes type 2 (before 1999) 
















3.2 Study populations and design 
Paper I  
This is a historical population based cohort study, with data obtained from CONOR and 
MBRN. The study population consisted of 2 645 women giving birth to their first child 
during 1994 – 2003 subsequent to their participation in CONOR (488 one-child mothers 
and 2157 women with ≥ 2 births of younger reproductive age 20-40) with linked data 
from the MBRN, and 1 677 nulliparous women (see Figure 3 for a flowchart with 
inclusions and exclusions for the study population). All parous women were examined 
before their first childbirth. This yielded a total of 4743 women in the study. Sub-
analyses included only women with reported partners as a proxy for exposure to 
pregnancy (ever) (228 nulliparous and 216 mothers with ≥ 2 births). 
 
Paper II 
This is a historical population based cohort study, with a collection of data from CONOR 
and the MBRN. The study population consisted of 32 618 parous women (4 490 one-
child mothers and 28 128 women with ≥2 children aged 20-69 years) examined after first 






























Pre-pregnant examination in CONOR 
(1994-2003) and linked to the MBRN  
4322 women 
Nulliparous or with singleton viable births ≥ 22 
gestational weeks 
            421 women 
-Pregnant at examination (139) 
-Unsure in pregnancy status (157),  





2157 women with 
≥ 2 children 
Text
Figure 3. Flow-chart of participants in Paper I  
<3 
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of children from the MBRN (1967-2008) (see Figure 4). To avoid misclassification of 
births that occurred before 1967, we included only women who reported no other births 

















Paper III  
This is a historical population based cohort, with data obtained from the MBRN and the 
National Education Database. We used personal identification numbers to link all births 
to their mothers, creating a sibship structure, with the mother as the observation unit. The 




study population consisted of 882 803 mothers giving birth to their first singleton infant 
(≥22 gestational weeks) during 1967 to 2007 who were followed for the occurrence of 
second birth in the MBRN until 2014 (see Figure 5 for a flowchart with inclusions and 









































































































3.3 Exposures, outcomes and confounding factors 
3.3.1 Exposures 
Papers I and II: Non-fasting lipid levels  
In CONOR lipid levels of total, HDL cholesterol, and TG levels were taken in non-
fasting state and measured by an enzymatic method. We calculated LDL using the 
Friedewald formula (94): Total serum cholesterol minus HDL cholesterol minus one fifth 
of the TG concentration. Due to the lower precision of calculation with highly increased 
TG levels, LDL cholesterol levels were calculated only for participants with TG 
concentrations < 4.5mmol/l (94). TG/HDL-c ratio was calculated as: TG concentration 
divided by HDL cholesterol concentration. We additionally used non-HDL cholesterol 
levels (calculated as total cholesterol minus HDL cholesterol) as a useful tool in 
individuals with higher TG levels (95) (paper II). We used total (mmol/l), LDL (mmol/l) 
and HDL cholesterol (mmol/L), and TG (mmol/L) and TG/HDL-c ratio (mmol/l) levels 
as categorical variables, calculating lipid quintiles. Lipid quintiles were calculated 
accordingly, on a total sample prior to pregnancy in paper I as well as on a post- 
pregnancy sample (paper II). 
Laboratory measurements (Papers I and II) 
Non-fasting blood samples were obtained by trained personnel and analyzed on a Hitachi 
911 Auto Analyzer (Hitachi, Mito; Japan) (88). Serum concentrations of total cholesterol, 
HDL cholesterol and TG were analyzed subsequent to sampling, with the use of reagents 
from Boehringer Mannheim (Mannheim, Germany). Total cholesterol and HDL 
cholesterol were measured by applying an enzymatic colourimetric cholesterol esterase 
method, with HDL cholesterol measured after precipitation with phosphortingsten and 
magnesium ions. An enzymatic colourimetric method was applied for measuring TG, 
while glucose was measured by using an enzymatic hexokinase method (96). The day-to-
day coefficients of variation were: total cholesterol: 1.3%-1.9%; HDL cholesterol: 2.4%; 






Paper III: Adverse outcomes in the first pregnancy 
 All exposure variables were obtained from the MBRN. Perinatal death included 
stillbirths and neonatal deaths within 7 days after delivery. Stillbirth was defined as 
stillborn with gestational age ≥ 22 completed gestational weeks. PTD was defined as 
delivery occurring before 37 completed weeks. SGA was defined as infant birth weight 
below the tenth percentile by gestational age and sex, based on a previous standard using 
data from MBRN (97). PE was defined as any recording of blood pressure of ≥ 140/90 
mmHg after 20 weeks of gestation with proteinuria ≥ 0.3 g/L per 24 hours, and included 
all forms of PE, eclampsia and syndrome of hemolysis, elevated liver enzymes and low 
platelet count (HELLP), in accordance with recommendations by the Norwegian Society 
of Gynecology and Obstetrics (98). To account for time trends of PTD, SGA, PE and CS, 
we analyzed our data by the following periods: 1967-1976, 1977-1986, 1987-1996, and 
1997-2007. We additionally examined the characteristics of the included women 
(maternal age, educational level, cohabitating status) during the same periods. 
 
3.3.2 Outcomes 
In paper I, the main outcomes were having no and one lifetime pregnancy (relative to 2 
or more pregnancies). Using the unique national identification number, each woman was 
linked to all her subsequent births (if any) in the MBRN after participating in CONOR 
(prior to pregnancy). Women reporting no children in CONOR at the time of 
examination and with no valid records in the MBRN were considered having no 
pregnancies. We defined one-child mothers as women being 6 years out from their first 
pregnancy and with no additional births registered in the MBRN. To extend each 
woman’s likelihood of completing her birth record, we separately examined women who 
were 7 years out from their first pregnancy. About 95% of Norwegian women will 
complete their second pregnancy within 7 years (3). In a subanalysis we used the 
presence of a partner (ever) as a proxy for exposure to pregnancy among nulliparous 
women, (nulliparous vs. women with ≥ 2 births), including only women with a reported 
partner (ever). 
In paper II, the outcome was the probability of having one lifetime pregnancy (relative to 
2 or more pregnancies). One child mothers were defined as women being 7 years out 
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from their first pregnancy and with no additional births in the MBRN, who participated 
in CONOR after their first childbirth. To minimize the effect of ageing, we included only 
women ≤69 years of age. 
In paper III, the main outcome was the risk of having one lifetime pregnancy (relative to 
2 or more pregnancies). One child mothers were defined as women being 7 years out 
from their first pregnancy and with no additional births registered in the MBRN (i.e. we 
included first births that occurred before 2007 and all women were followed until 2014 
for the occurrence of a second pregnancy). 
 
3.3.3 Potential confounders 
From CONOR (Papers I and II) 
In Paper I, the covariates were obtained from CONOR and based on a sample prior to 
pregnancy. These included age at examination, level of education (categorized in: <11 
years and >11 years of education), smoking (current smoker: yes, no), time since last 
meal (linear term), oral contraceptive (OC) use (now, previously, never) and body mass 
index (BMI) (linear term). Age at examination/participation in CONOR was used as a 
continuous variable in all analyses in papers I and II. Age is associated with both lipid 
levels and female fertility (68, 78), and these data were complete. Attained level of 
education was obtained from standardized questionnaires and was missing for 49 
(1.13%) women. Educational level is a commonly used measure of socioeconomic status 
in epidemiologic research (99), and can, therefore, serve as a proxy for lifestyle factors. 
Smoking questions included two options (daily smoker now or not a daily smoker now). 
We classified women as ’current smoker’ or ’not a current smoker’ (yes or no). There 
was 20 (<0.5%) women with missing data on smoking. Smoking adversely influences 
female fertility (100) with most of its effects attributed to HDL cholesterol decrease 
(101). However, the smoking status of participants was only available at enrolment of the 
study, and this represents a limitation. Frequency of smoking (number of cigarettes per 
day), as a measurement of smoking intensity, was not taken into account due to a high 
number of missing data on this variable. Time since last meal was used as a continuous 
variable to account for temporal proximity of food intake, and these data were complete 




levels seem to be less sensitive (102). OC use was assessed by questions on the use of 
contraceptive pills, which included three options (use or ever used contraceptive pills: 
now, previously, never). OCs are shown to affect both serum level of TG (68, 73) and 
female fertility. There were 20 (<0.5%) women with missing data on OC use. Body mass 
index (BMI) was used as a continuous variable. BMI was calculated as kilograms per 
meter squared (kg/m2) and both body weight (kg) and height (cm) were measured 
according to a standard protocol in CONOR. These measurements were manually 
recorded by the year 2000, and with an electronic Height and Weight Scale thereafter 
(96). BMI is a factor known to affect serum lipid levels and is also found to be associated 
with lower fertility (103, 104). We also assessed the effect of BMI by stratifying our 
results by women’s pre-pregnancy BMI (paper I), as well as post-pregnant BMI (paper 
II).  
In Paper II, we used the same covariates as in paper I, however, based on a sample after 
the first pregnancy. In addition, we used the variable ‘year of first birth’. The temporal 
proximity of childbirth is associated with both lipid levels and chances of subsequent 
pregnancy, as recent pregnancy affects serum lipid levels and conception (83). Besides 
accounting for time elapsed since first birth, year of first birth was also used as a proxy 
for generational/environmental factors (105). This covariate was not a significant 
predictor in the pre-pregnancy sample (Paper I), and was, therefore, not included in the 
model.  
Questions on self-perceived health included 4 options (What is your current health status: 
poor, not so good, good, very good). Answers ‘poor’ and ‘not so good’ were classified as 
‘bad’, while ‘good’ and ‘very good’ were classified as ‘good’ perceived current health. 
Self-perceived health (good and bad), education (<11years and >11 years) and BMI (<25 
and ≥25) were also assessed in stratified analyses. Missing data were low for the majority 
of parameters, and were as follows: education 276 (0.8%), smoking 230 (0.70%), time 
since last meal 1416 (4.3%), OC use 1319 (4.0%), BMI 51 (0.16%), self perceived health 
220 (0.8%). 
In a subanalysis, we explored the family history of CVD by using women with reported 
heart attack and/or angina in siblings and/or parents (missing data: 0.4%). Information on 
alcohol use and vigorous physical activity was missing for 5.8% and 10.8% of women, 
respectively, and was therefore only included in subanalyses.  
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From the MBRN/the National Education Database (paper III) 
In Paper III, the covariates included maternal age at first birth, education and year of 
childbirth.  Maternal age at first birth was used as a continuous variable. Maternal age is 
a factor associated with both female fertility and adverse pregnancy outcomes (26). The 
educational level contains information on the highest attained education. Data on 
education was missing for 1.1% of women, while maternal age and year of childbirth 
were complete. Year of firstchildbirth was used as a continuous variable and was applied 
to account for potential cohort effects (105).  Marital status included categories: married, 
cohabitant/registered partner (registered from 1977 and 2008, respectively), 
unmarried/single, divorced/separated (including widowed) and was included in a 

















3.4 Statistical analyses 
Paper I  
Analyses were performed using the Statistical Package for Social Sciences (SPSS, 
version 22.0 and 23.0, Chicago, Illinois). Characteristics of the analyzed women were 
presented as means with standard deviations for continuous data and as numbers with 
percentages for categorical data. Differences between nulliparous women, one-child 
mothers and mothers with two or more children, as well as pre-pregnant health status 
were analyzed by Chi-square tests and t-tests where appropriate. Linear associations 
across pre-pregnant lipid levels (in quintiles) for no and one lifetime pregnancy were 
assessed by p-values for trend. Odds ratios (OR) with 95% confidence interval (CI) of no 
and one lifetime pregnancy by lipid levels and TG/HDL-c ratio, when compared to 
women with two or more pregnancies were calculated using multinomial logistic 
regression and adjusted for mother’s age at examination, level of education (categorized 
in: <11 years and >11 years of education), smoking (current smoker: yes, no), time since 
last meal, OC use (now, previously, never) and BMI (linear term). To test the effect of 
(pre-pregnant) BMI, we stratified the main analyses by BMI (<25 and ≥ 25). To avoid 
influence from age at first delivery on the number of children, we excluded women older 
than 34 years at the time of first delivery in a subanalysis. Additionally, we performed 
sensitivity analyses including only mothers who were 22-30 years old at the time of first 
delivery. Using the presence of a partner as a proxy for exposure to pregnancy among 
nulliparous women, we performed logistic regression in a sub-analysis (nulliparous vs. 
women with ≥ 2 births) including only women with a reported partner.  
Paper II  
Statistical analyses were done using SPSS, version 25, Chicago, Illinois. Baseline 
characteristics were presented as means with standard deviations (continuous data) and 
numbers with percentages (categorical data). Differences between lipid quintiles were 
assessed by p values (Wald test) and between one-child mothers and mothers with two or 
more children, using Chi-square test and t-test, where appropriate.  
We used logistic regression to calculate ORs for one lifetime pregnancy by lipid levels. 
Estimates were adjusted for mother’s age at examination (linear term), year of first birth 
(linear term), BMI (linear term), OC (now, previously, never), smoking (at examination: 
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yes, no), education (≤11 years (low), >11 years (high)) and time since last meal (linear 
term). Besides accounting for time elapsed since first birth, year of first birth was also 
used as a proxy for generational/environmental factors (105). OC use was defined as 
current use of OC, previous use or never.  Effect of BMI (<25 and ≥25), self-perceived 
health (good and bad) and education (high and low) were also assessed in stratified 
analyses. Answers ‘poor’ and ‘not so good’ were classified as ‘bad’, while ‘good’ and 
‘very good’ were classified as ‘good’ perceived current health. We performed a 
sensitivity analysis on women <40 years of age to explore the effect of menopause on 
women’s lipid profile. Missing data were low for the majority of parameters, and were 
excluded from the main analyses, except for the OC use. Due to higher numbers of 
missing values for serum glucose, this variable was excluded from further analyses.  
 
We compared the occurrence of IVF in the first pregnancy, diabetes, use of 
antihypertensive medications, PCOS, and thyroid disease between one-child mothers and 
women with two or more children. We also excluded women using antihypertensives in 
the main analyses. 
In subanalyses, we explored the impact of past-year physical activity (≤1 hour per week 
and ≥1 hour per week) and alcohol use (≤1 time per month and >1 time per month). We 
also excluded women with reported heart attack and/or angina in siblings and/or parents, 
with the additional exclusion of women with diabetes in parents. 
In order to assess how robust the associations are to potential unmeasured confounding, 
we calculated E-values (106) for both the main analyses and sensitivity analysis on 
women <40 years of age. The E-vale is defined as “the minimum strength of the 
association, on the risk ratio scale, that unmeasured confounder would need to have with 
both the exposure and the outcome to fully explain away this exposure-outcome 
association, conditional on the measured covariates” (106). 
 
Paper III  
Statistical analyses were performed using Stata Software, version 15 (StataCorp. College 




and proportions. Differences between one child mothers and mothers with two or more 
children were analyzed by t-test and Chi-square tests. For each of the adverse outcomes 
of pregnancy (PTD, SGA, PE and CS) a four-category variable was created: 1) women 
with the outcome and a live infant, 2) women without the outcome and with loss 3) 
women with the outcome and loss and 4) women with no adverse outcome and no loss 
(reference category). Each appropriate category of complication included only the 
complication in question (stated) and no other observed complications. We used 
generalized linear models for the binary family to calculate crude and adjusted relative 
risks (RRs) with 95% CI for having one lifetime pregnancy in women experiencing the 
adverse pregnancy outcomes compared to women without these conditions. Analyses 
were adjusted for maternal age as a six categorical variable (years: <20, 20-24, 25-39, 
30-34, 35-39 and >40), attained education as a two categorical variable (years: <11 and > 
11) and year of first childbirth (continuous). We also constructed a composite variable 
that combined the effect of two, three and all four outcomes on the risk of having one 
lifetime pregnancy, and stratified this analysis by perinatal loss. We explored possible 
interactions between the observed outcomes and perinatal loss by examining the 
statistical significance of interaction terms. Due to an overall higher risk of pregnancy 
complications among women with multiple pregnancies (24), we included only women 
with singleton first births in our analyses. In subanalyses, we excluded women with 
preexisting diabetes, previous hypertension, IVF pregnancies (from 1988) and women 
with chronic conditions (asthma, chronic renal disease, cardiovascular disease and 
rheumatoid arthritis) and performed stratified analyses on marital/cohabitant status (to 
examine the effect of having a partner). We truncated the data to allow all included 
women at least a 7-year timeframe to complete their birth record (i.e. we included first 
births that occurred before 2007, and all women were followed until 2014 for the 
occurrence of a second pregnancy) (3). Due to the low number of missing cases (1.1% 
for education and 0.48% for marital status), these were handled by a listwise deletion in 
the analyses. Additional exclusion of women with missing data on education and 
cohabitation showed no effect on our results. The proportion of missing data for other 
variables were low: birthweight (0.16%) and gestational age (5.0%), and these were 
excluded from our calculations for the 4-level variable.  
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3.5 Ethical considerations 
All three studies were approved by the regional ethical review board REK-Vest (Ref 
numbers: Paper I and II: 2013/118; Paper III: 2009/1868) and access to data was 
granted by the Steering Committee for CONOR and by the MBRN.  
 
Our studies used banked blood samples collected in CONOR, and subjects were not re-
contacted for the analysis. Written informed consent included use for research and 
linkage to health registries, and was obtained for each participant. Personal identification 





4. Summary of main results 
4.1 Paper I 
There were 4 743 women with a baseline assessment of lifestyle factors in CONOR 
(1994-2003) that were linked to the MBRN. We excluded 421 women with pregnancy at 
the time of examination (n =139), unsure pregnancy status (n =157) and missing lipid 
assessments (n =125). Thus, 4 322 women were included in the analyses (1 677 
nulliparous, 488 one-child mothers and 2 157 women with ≥ 2 births). Sub-analyses 
included only women with reported partners (228 nulliparous and 216 mothers with ≥ 2 
births). 
 
Assessed in quintiles, higher pre-pregnant TG and TG/HDL ratio levels were associated 
with increased risk of one lifetime pregnancy compared to having ≥ 2 children. 
Compared to the highest quintile, women in the lowest quintile of HDL cholesterol had 
an increased risk of one lifetime pregnancy (OR 1.7 95% CI 1.2-2.4), as were women 
with the highest LDL cholesterol, TG and TG/HDL ratio quintiles (compared to the 
lowest) (OR 1.2 95% CI 0.8-1.7; OR 2.2 95% CI 1.5-3.2; and OR 2.2 95% CI 1.5-3.2, 
respectively). Similar effects were found in women with BMI ≥ 25 and the highest LDL 
and total cholesterol levels in risk of lifetime nulliparity. 
 
Nulliparous women were older at the time of examination, had higher BMI and were 
more frequent smokers compared with women with two or more births. A higher 
proportion of nulliparous women had >11 years of education. One-child mothers had 
higher mean age both at the examination and at delivery (29.5 vs. 26.7 and 32.3 vs. 29.9, 
respectively), were more often smokers and had lower education than mothers with ≥ 2 
births. The mean BMI prior to pregnancy was higher in one-child mothers (24.2 vs. 
23.5), whereas mean years from examination to first delivery were similar for the two 
groups. Women with no and one child were less frequent users of OCs at the time of 
examination compared to mothers with ≥ 2 births (27.4%, 34.6% and 48.9%, 
respectively). 
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The proportion of diabetes at first delivery in one-child mothers was higher than in 
women with two or more births (1.4% versus 0.9%, p =0.30). A significantly higher 
number of one-child mothers had IVF in their first pregnancy (7.2% versus 2.6% in 
women with ≥ 2 births, p< 0.001).  
Similar effects of pre-pregnant lipids as in one child mothers were observed when 
subanalysis (nulliparous vs. ≥ 2 births) were performed on women who had a partner (as 
a proxy for ever being exposed to pregnancy). In women with a partner, risk of having no 
children was increased among women in the highest quintiles of TG and TH/HDL-c ratio 
(compared to the lowest quintiles) and also for those in the lowest HDL quintile 
(compared to the highest) (OR 1.9, 95% CI 0.9-4.2; OR 2.0, 95% CI 1.0-4.1; and OR 1.6, 
95% CI 0.7-3.6, respectively). 
 
4.2 Paper II  
We used data on 32 618 parous women (4 490 one-child mothers and 28 128 women 
with ≥2 children) examined after first childbirth as part of CONOR (1994-2003) with 
linked data on reproduction and number of children from the MBRN (1967-2008). ORs 
for one lifetime pregnancy for the highest quintiles of LDL and total cholesterol 
(compared to lowest quintiles) were 1.30 (95%CI: 1.14-1.45) and 1.43 (95%CI: 1.27-
1.61), respectively. Additional analyses on non-HDL cholesterol showed similar results 
as for LDL levels. Sensitivity analysis (women <40 years) showed no appreciable change 
in our results.  In stratified analyses, estimates were slightly stronger in 
overweight/obese, physically inactive and women with self-perceived bad health 
One-child mothers had significantly more IVF in the first pregnancy (1.3% vs. 0.1%, 
p<0.001), were more frequent users of antihypertensive medications (3.6% vs. 2.9%, 
p=0.01), had slightly higher proportion of stroke (0.6% vs. 0.4%, p=0.05) and a 
significantly lower proportion of thyroid disease (0.5% vs. 1.0%, p<0.001), compared to 
women with two or more children. Exclusion of all women with thyroid disease from our 
main analyses did not affect the results. Diabetes (1.1% vs. 0.9%) and history of heart 




with two or more births. Exclusion of women on antihypertensive therapy did not alter 
the main results. 
E-value calculations showed that an unmeasured confounder would need to have nearly 
four times as large an effect as maternal age (covariate with the strongest effect in the 
adjusted model, with Exp (B)=1.13), and be associated with both the exposure and the 
outcome to completely explain away the observed associations (106). 
After excluding 12 730 women with reported CVD in parents or siblings and 144 women 
with missing information, risks of one lifetime pregnancy by lipid quintiles increased 
slightly across LDL and total cholesterol levels. Additional exclusion of diabetes in 
parents did not affect the results. Stratified analyses on alcohol use showed the only 
slight modifiable effect of alcohol on lipid levels.  
 
4.3 Paper III 
We identified 882 803 women giving birth to their first singleton infant (≥22 weeks) 
between 1967 and 2007, of which 16 % had only one lifetime pregnancy. These women 
were older at first delivery, had less education and a higher proportion of unmarried 
compared to women with two or more births. In women with pregnancy complications 
where the infant survived the perinatal period, RRs for one lifetime pregnancy were 
increased (PTD: 1.21 [1.19-1.22], SGA: 1.13 [1.12-1.15], PE: 1.09 [1.07-1.11], CS: 1.24 
[1.23-1.25]), but significantly reduced if the child was lost (PTD: 0.63 [0.59-0.68], SGA: 
0.57 [0.51-0.63], PE: 0.69 [0.59-0.80], CS: 0.67 [0.56-0.79]), compared to women with 
no perinatal loss and no adverse outcome.  
Tests of interaction between PTD, SGA and CS at first birth and loss showed a 
significant effect on the risk of having one lifetime pregnancy (P=0.001, P=0.005 and 
P<0.001, respectively). We found no significant interaction between PE in first birth and 
loss (P=0.47).  
Exclusion of women with preexisting diabetes, hypertension and IVF pregnancies (from 
1988) did not substantially change the results. Additional exclusion of asthma, chronic 
renal disease, cardiovascular disease and rheumatoid arthritis showed only slight effect 
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for women with a surviving child (PE: (crude) RR 1.15, 95% CI 1.13-1.17 and CS: 
(crude) RR 1.65 95% CI 1.63-1.68), while for women with no loss results remained 
unaltered. Stratification by marital/cohabitating status showed a decrease in RRs of 
having one lifetime pregnancy among unmarried and single women with observed 
complications, implicating effect of having a long-term partner. In our examination of 
changes in maternal characteristics throughout 4 decades of MBRN, we found an 
increase in the proportion of one child mothers (first vs. last decade: 14.4 % vs. 18.4%) 
with more than doubled proportion of women aged ≥35 at first birth. In the same group, a 
decrease in the number of single women for almost one third was accompanied with a  
7.6% increase in education level. Similar to the results for the separate effects of the 
outcomes, the analyses for the composite variable showed that the increased risk of 







5.1 Methodological considerations and limitations 
5.1.1 Design 
The main advantage of registry data is that they are readily available (107) and 
comprise a collection of data for several decades, offering unusual possibilities for 
research across generations (107). As suggested in a recent commentary (107), the 
MBRN along with other Nordic Medical Birth and population registries and tissue 
biobanks, are considered “a potential goldmine for future clinical and 
epidemiological research”. The lack of biological material is a disadvantage in 
ordinary register-based research (107), however, in this thesis we were able to link 
national cohort data (CONOR) with biological material (papers I and II) and register 
data from the MBRN, bringing a new possibility to explore the outcomes of interest. 
Women who gave birth at the time of the establishment of the MBRN (1967) have 
now reached the age of 60-80 years, enabling us to investigate the relation between 
prepregnant health, health in midage, as well as the effect of reproductive history and 
pregnancy complications in this age group. This, however, may not apply for the 
younger cohorts of women (i.e. Paper I), which is a common limitation in the 
registry-based studies. Another limitation of registry-based design is that data 
consists of predefined variables (not available for researchers to influence data 
collection), however, this is outweighed by the great number of study objects 
available for research. This makes the detection of moderate risk factors possible 
(paper III) (107), and also provides a unique opportunity to explore the effect and 
associations of rare events (perinatal death, PTD) (paper III).  
 
5.1.2 Precision 
As precision refers to the lack of random error, options to increase precision include 
increasing study size and modifying study designs (108). Since the confidence intervals 
reflect both the strength and the direction of the association, these parameters also offer 
information on precision and random variation of the estimates (109). In papers II and 
III, the study sizes were large, with generally precise association measures and narrow 
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confidence intervals. For paper I, the study size was smaller with wider confidence 
intervals, however, the precision of the estimates was not problematic. In sub-analyses, 
fewer participants may have hampered the results.  
 
5.1.3 Validity  
Internal validity 
Internal validity can be referred as “the degree to which a study is free from bias or 
systematic error” (110), and implies the validity of a conclusion to the source population 
(109). There are three main sources of bias that can violate the internal validity: 
information bias, selection bias and confounding (109). 
 
Information bias (misclassification) 
Information bias or misclassification occurs when there are measurement errors in the 
information about study participants, the exposures or the outcomes. These errors can 
lead to non-differential or differential misclassification. Rothman describes these in the 
following way: "For exposure misclassification, the misclassification is nondifferential if 
it is unrelated to the occurrence or presence of disease; if the misclassification of 
exposure is different for those with and without the disease, it is differential. Similarly, 
misclassification of disease [outcome] is nondifferential if it is unrelated to the exposure; 
otherwise, it is differential" (109). In large registry-based data, despite registry quality 
controls, errors in registration of both outcomes and exposures may be seen. However, 
any misclassification of this type would most likely be non-differential.  
 
Misclassification of exposures 
Very few women in our samples had a lack of information about the main exposures 
(lipid assessments and pregnancy complications). Lipid assessments were obtained from 




total, HDL cholesterol, and TG levels, taken in a non-fasting state. Laboratory 
measurements were performed by an enzymatic method (88). Due to better capture of 
dose-response effect, we used quintile distribution instead of cut-off point or continuous 
variable. Accordingly, quintiles were calculated on a total sample of women prior to 
pregnancy (paper I), and on a total sample after pregnancy (paper II).  In paper I, we had 
missing data on 16 cases of LDL, 2 cases of TG, and 2 cases of TG/HDL ratio. In paper 
II, all missing lipid level assessments were excluded from the analyses, and additional 
missing value exploration has not shown any disturbing patterns.  
 
Non-fasting state of participants when collecting lipid levels is stated as a limitation in 
this study, as TG levels are more sensitive to recent food intake, while cholesterol levels 
seem to be less affected (102). However, adjustments for time since last meal did not 
show appreciable changes in results in Paper I and Paper II. In addition, since it is 
unlikely that women’s fasting status is related to the number of children, any bias arising 
from this is likely non-differential.  Non-fasting lipids have successfully been used in 
lipid and CVD research (73, 111, 112).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
Moreover, non-fasting TG levels have been suggested to show a better predictive 
capability for CVD in women than fasting TG levels (113). Measurement errors during 
blood sampling and laboratory assessments cannot be excluded. However, the 
automatization of the process and standardization of the laboratory measurements, along 
with sampling performed by highly trained and experienced personnel (88, 96) 
minimizes the likelihood of bias.  
In paper III, information on the exposures was extracted from the MBRN. National 
guidelines for diagnosis and monitoring of maternal and fetal complications have been 
updated regularly since 1995, but lack of adherence may be present. (114). Although we 
had limited registration of ultrasound based gestational age (from 1999 onwards), 
possible errors in gestational age estimates (last menstrual period vs. ultrasound-based) 
are not likely to be substantial in MBRN (25). Validation studies showed good 
ascertainment of PTD with PPV 90-93% (93). Although overall reporting of PE was 
satisfactory (91), the underreporting of milder cases might be present. While the 
experience of PE might be linked with the number of children finally born by a woman, 
for the mild forms, unrecognized by either a mother or health personnel, this is not likely 
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to be the case. Therefore, if present, this would represent a non-differential 
misclassification. 
 
Misclassification of outcomes 
Given the lack of information on women’s reproductive planning in our data in paper I, 
the heterogeneity of causes for childlessness among nulliparous women may be present 
(including women who are voluntary childless or have not been exposed to pregnancy 
(ever)). Thus, the increase in risk of having no children may be underestimated in paper 
I. We tried to address this in subanalyses including only women with a reported partner 
as a proxy for exposure to pregnancy among nulliparous women. We found that the 
results for nulliparous women were similar to our main results for one-child mothers. 
Women with a reported partner had a higher risk of having no children (compared to 
partnered women with ≥ 2 births) if their TG and TG/HDL-c ratio levels were in the 
highest quintiles and HDL in the lowest quintile. These findings support the role of 
serum lipids in lifetime nulliparity among women with partners.  
In paper I we defined one-child mothers as women being 6 years out from their first 
pregnancy and with no additional births registered in the MBRN. It is possible that this 
selection may include some mothers that gave birth to a second child during the 7th year, 
thus being a 2+-child mother. Misclassification of the outcome will generally bias the 
results towards the null, so the true effect may be greater. However, truncation of data to 
extend the time to 7 years did not appreciably alter the results (subanalysis). Thus, we 
conclude that the misclassification of one-child mothers is not likely to have occurred.  
In paper II, we used the same principle of identifying one-child mothers and 2+ child 
mothers as in paper I. The 7-year follow up on successive delivery allows sufficient 
observation time for new childbirths to occur (3). The big sample size and long follow up 
for the occurrence of a second birth further minimized the risk of misclassification of 
outcomes. In paper III, identification of one-child mothers and mothers of 2+ children 
was based on a large sample size from MBRN. We had a complete registration of all 
births linked to the mother through her unique personal identification number. One-child 
mothers were defined as women being 7 years out from their first pregnancy and with no 






As defined by Rothman (109), confounding refers to a mixing of the effect of the 
exposure with the effect of another variable on the outcome. Confounder, thus, represents 
variables that are associated with the exposure and with the outcome but is not presumed 
to be a causal consequence of the exposure (109). 
Confounders may be stratified on or adjusted for to block confounding paths (108). For 
the studies included in this thesis, confounders were identified a priori, based on existing 
literature.  
In paper I, adjusting for age at examination, level of education, smoking, OC use, and 
BMI led to the strengthening of results while adding time since last meal to the model 
showed minimal effect. Time from examination to first birth showed not to be a 
significant predictor (and showed no effect on our results), and was therefore not 
included in the model. To study more closely the effect of prepregnancy BMI, we 
stratified analyses by BMI. This led to the strengthening of results in the strata of women 
with BMI ≥25, while the risks remained, albeit slightly attenuated in BMI<25.  
In paper II, we both stratified analyses and adjusted for a range of potential confounders, 
similar to paper I, with additional adjustments for year of the first birth. We found that 
age at examination, OC use and BMI attenuated the results, while adding smoking, 
education and year of the first birth strengthened the results. Time since last meal only 
slightly attenuated the risks. We further stratified analyses by BMI, family history of 
CVD, selfperceived health status and education. We explored the effect of menopause in 
a sensitivity analysis, selecting the women below 40 years of age. This provided only 
slight attenuation from our main results. In subanalyses, we stratified by alcohol use and 
vigorous physical activity. The physical activity showed decreasing effects on lipid 
levels. Alcohol use showed a stronger effect on LDL levels, while for the total 
cholesterol levels we found OR alteration in low frequency users and decreased OR for 
high frequency users. This may reflect a reluctance to report drinking frequency in the 
low frequency group or that abstinence from alcohol is marker of other unmeasured risks 
(111). 
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The common limitation for all three studies in this thesis was the lack of information on 
women’s family decision planning. Unfortunately, these types of data are not routinely 
collected in birth registries and health surveys and are available only in appropriate 
specialized clinics and/or surveys, which usually suffer from small sample size. In paper 
I, we tried to address this by using the presence of a partner and/or marital status as a 
proxy for exposure to pregnancy. In addition, covariates in papers I and II are measured 
at one point in time (CONOR) and changes in risk factors over time could not be 
assessed (i.e. the smoking status of the participants was available only at the enrollment 
in the study). Furthermore, we lacked information on apolipoprotein E genotype, c-
reactive protein (CRP), sex hormone status dietary intake or stress and thyroid 
tests/antibodies, factors that are all found to affect female fertility (79) and residual 
confounding by those factors cannot be excluded. However, we additionally calculated 
E-value to assess the robustness of the associations to potential unmeasured confounding 
(Paper II). In addition, the exclusion of women with thyroid disease in Paper II showed 
no effect on our results. Lastly, we had only 4 cases of PCOS in our samples, thus under-
reporting might be present.  
In paper III we adjusted for a limited number of potential confounders. For women with 
complications and no loss, change of RR towards the null after adjustments suggests that 
the observed associations between adverse outcomes and the probability of one lifetime 
pregnancy were partially explained by adjusted factors, with maternal age at first birth 
changing the estimates the most. The associations, however, became stronger after 
adjustments for women with complications and a loss. Smoking and BMI have not been 
registered in the MBRN before 1999 and 2006, respectively. Due to truncation of our 
data to first births before 2007, we did not include smoking and BMI in adjustments in 
order not to decrease the power of the study. The lack of adjustments for smoking and 
BMI represents a limitation in the study. Level of education may serve as a proxy for 
BMI as higher education correlates with lower BMI (115) and adjustments for education 
may partially have accounted for BMI. Smoking is associated with a higher risk of 
pregnancy complications and stillbirth (100). However, we do know that smoking among 
pregnant women in Norway has declined tremendously during the last decades (111). 
The unmeasured confounding will always be an issue in observational studies, however, 
the stability of our results over the 4 examined decades, despite increasing obesity rates 




not the primary determinants of the observed association. Other limitation included lack 
of information on fertility treatments other than IVF. Residual confounding by CS 
indication cannot be excluded, however, exclusion of women with selected chronic 
conditions makes these less likely as indications. A Norwegian study found the results 
consistent in both high and low risk cesarean delivery, implicating cesarean delivery as a 
reason for reduced fertility, and not the indications that led to it (24). Validation studies 
showed good ascertainment of pre-gestational diabetes, however, the possibility of 
underreporting of type 2 diabetes (until 1999, when the new form was introduced) might 
be present (92).  
 
Mediation 
In epidemiologic studies, the concept of confounders and mediators are not always 
readily distinguishable (116). In that respect, some confounders may be potentially also 
regarded as mediators. One such variable in our studies might be BMI. In papers I and II, 
we decided not to do a mediation analysis, since the criteria for a mediator was not 
fulfilled (i.e. the mediator is a presumed causal consequence of a predictor) (116), given 
that BMI status preceded blood lipid measurements. Instead, to study more closely the 
effect of BMI, we stratified by prepregnancy (paper I) and postpregnancy BMI status 
(paper II) in our studies.  
 
Interaction 
Interaction can be defined as “variation in the selected effect measure for the factor under 
study across levels of another factor” (110). In paper III, we explored possible 
interactions between the observed outcomes (PTD, SGA, PE and CS) and perinatal loss 
by examining the statistical significance of interaction terms. Tests of interaction 
between PTD, SGA and CS at first birth and perinatal loss showed a significant effect on 
the risk of having one lifetime pregnancy. There was no evidence of significant 





VanderWeele and Ding (106) recently proposed a standardized approach to sensitivity 
analyses for confounding. They introduced the E-value, defined as “the minimum 
strength of the association, on the risk ratio scale, that unmeasured confounder would 
need to have with both the exposure and the outcome to fully explain away this 
exposure-outcome association, conditional on the measured covariates” (106). 
We performed E-value calculations accordingly (for the common outcomes - >15% 
prevalence) (106): 
 
! − !"#$% = !!∗  + sqrt !!∗   × !!∗   − 1  
 
* When the outcome is common (more than 15%), an approximate E-value can be 
obtained by replacing the risk ratio with the square root of the odds ratio, i.e. RR*≈sqrt 
(OR), in the E-value formula (106). 
In paper II, in order to assess how robust the associations are to potential unmeasured 
confounding, we calculated E-values for both the main analyses and sensitivity analysis 
on women <40 years of age.  
 
Selection bias 
Selection bias occurs when the subjects studied are not representative of the target 
population about which conclusions are about to be drawn (109). It refers to an error 
caused by influencing factors that affect the selection of study subjects or participation in 
the study (109). Paper III was based on the MBRN, which is a nationwide register based 
on a compulsory notification of all births (with a very low dropout rate) (107). Therefore, 
the possibility of selection bias in this study is very low. In papers I and II, the design of 
the studies included linkage between CONOR and MBRN, creating a cohort of women. 
One of the two main sources of selection bias in cohort studies is the loss to follow up. In 




had one lifetime pregnancy were more likely to emigrate than future mothers of 2 or 
more children, prior to their first births. No notable differences in observed emigration 
status were observed between women with one lifetime pregnancy and those with 2 or 
more pregnancies, and the same was true for paper II (post-pregnancy sample). 
Therefore, it is unlikely that loss to follow up would introduce systematic bias in our 
results, while a life-long personal identification number (given to all Norwegian 
permanent residents) minimizes the other sources of loss to follow up. Another common 
source of selection bias is non-participation. The overall participation rate in CONOR 
was 58%, which is qualified as fairly good (88). However, as we only observe those who 
agree to participate in the study, this may be affected by a possibility that individuals 
who choose to take part in a study may have different characteristics compared to the 
general population. Although non-participants are more likely to belong to lower social 
class, have lower health awareness and lifestyle factors (117), it has been reported that 
large population-based studies are generally robust against bias arising from self-
selection of participants (117).  
 
External validity 
External validity or generalizability is defined as “the degree to which results of a study 
may apply, be relevant or be generalized to populations or groups that did not participate 
in the study” (110). 
Paper II and III in this thesis are large registry based studies. Given the nationwide 
character of birth notification in the MBRN, our results should be applicable to all 
Norwegian women who gave childbirth. However, using national population data implies 
possible differences from other populations concerning race and ethnicity, lifestyle and 
health status. Regarding the effect of observed pregnancy complications on women’s 
future reproduction, it is likely that industrialized countries with a similar level of 
obstetric interventions and facilities for treating preterm babies will show similar results. 
Existing social policies supportive of high reproduction and other similarities within 
Nordic countries makes the results from this thesis highly applicable to this region, 
however, caution is needed with regard to the countries with restrictive reproductive 
policies (i.e. former ‘one-child policy’ in China). Due to a smaller sample size in paper I, 
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the same caution applies regarding the generalizability of results to other populations of 
reproductive aged women. However, given the increased risk of CVD in women with 
low parity worldwide (32, 33, 34), and our indications of possible biological 
underpinnings of this association, it is our belief that our results are relevant to other 




















5.2 Discussion of main results  
5.2.1 Paper I 
We found that women’s pre-pregnant lipid levels were associated with having one 
lifetime pregnancy. Women with high levels of LDL, TG and TG/HDL-c ratio as well as 
low HDL levels, measured years before conception, were at increased risk of having only 
one lifetime pregnancy. High levels of LDL and total cholesterol were associated with 
having no children, while in overweight and obese women this was true for all the 
examined lipids. 
Currently, different factors affecting fertility are vigorously discussed in the literature (1, 
7, 8, 52). Our findings contribute to the debate by providing a possible biological 
underpinning for a joint mechanistic pathway for reduced fertility and cardiovascular 
conditions (70). Findings suggest that the previously observed association between low 
parity and increased CVD risk may be confounded by preexisting adverse lipid levels, as 
unfavourable lipid profiles are found to be related to both subfertility and later CVD. 
Our findings are in line with both animal and human studies that link fertility with lipids 
(70, 72, 73, 118). The LIFE study has reported concentrations of free cholesterol to be 
associated with human fecundity in both sexes (73). Due to our focus on metabolic 
aspects of lipid profile in relation to fertility (and possible CVD risk), we have chosen 
TG/HDL ratio over traditional lipid ratios due to its stronger correlation with insulin 
resistance (119). Recent insights of TG/HDL-c ratio as a reliable indicator of insulin 
resistance and atherogenicity (120) highlight its ability to identify insulin resistance in 
apparently healthy individuals (81). Therefore, the observed higher levels of TG/HDL-c 
ratio in our study may be indicative of possible preexisting metabolic risk factors among 
women with one lifetime pregnancy, as well as in nulliparous women (overweight and 
obese, nulliparous with a reported partner). These findings also mirror increasing rates of 
infertility in both sexes among the population with metabolic syndrome (73). This notion 
is further supported by the higher proportion of diabetes in one-child mothers of 
reproductive age and a substantially higher proportion of IVF treated pregnancies, which 
remains after exclusion of women older than 34 years at the time of first delivery. 
Obesity is a well-established risk factor for both metabolic and fertility irregularities 
(103, 104). To look more closely into the effect of obesity, we stratified analyses by 
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BMI. As expected, we observed stronger effects among overweight and obese women, 
however, the higher risk of having only one child remained in normal weight women 
(BMI< 25) with the lowest HDL quintile and the highest TG and TG/HDL-c ratio 
quintiles. These findings reflect observations of metabolic irregularities among normal 
weight women as an independent risk factor for fertility disorders (121, 122). Recent 
genetic reports show that metabolic risk appears to be generated by different pathways in 
normal weight and obese subjects (123), proposing the so-called Metabolically 
Unhealthy Normal Weight phenotype.  
Women with one lifetime pregnancy had generally poorer lifestyle factors (BMI, 
smoking), were older and less educated. It is possible that unfavourable socioeconomic 
status, reflected in lower educational level (4), could be a hindering factor for further 
reproduction. However, a study exploring age at first birth, parity and post-reproductive 
mortality suggests that late childbearing in itself may be a signal of the preexisting poor 
health of a woman (124). Recent reports show that infertility diagnosis or undergoing 
fertility treatment is associated with increased risk of maternal morbidity compared to 
women without fertility problems (125).  
Given the lack of information on women’s reproductive planning in our data, the 
possibility for variability in reasons for childlessness among nulliparous women in this 
cohort could be present. This could also explain the observed risk differences between 
nulliparous women and one-child mothers in our main results, as the risk may be diluted 
by low risk groups of women who did not want children (126) or have not been exposed 
to pregnancy (ever). We tried to address this in a subanalysis by including only women 
with a reported partner as a proxy for being exposed to pregnancy. We observed results 
similar to our main results for one-child mothers, suggesting the role of serum lipids in 
lifetime nulliparity for partnered women.   
We lacked data on Apolipoprotein E genotype, CRP and thyroid tests/thyroid antibodies, 
factors that all are found to affect female fertility (79). We also had no available 
assessments of duration or temporal proximity of OC use, dietary intake or stress, 
therefore unmeasured confounding cannot be ruled out. Smoking adversely influences 
female fertility (100) with most of its effect attributed to HDL cholesterol decrease (101). 
We accounted for this in our analyses; however, smoking status of participants was only 




5.2.2 Paper II  
Given that lipid levels are susceptible to change during women’s lifespan, influenced by 
both pregnancy and menopause (127, 128), we wanted to explore women’s lipid status 
after childbirth. The ideal situation for testing our hypothesis would be to assess women 
that were analyzed several times both before and after their pregnancies. However, since 
this was not possible to achieve in our sample, we used a large sample of roughly 33 000 
women with post-pregnancy measures to study their lipid profile. These women were 
different from the women examined in paper I. 
We found that women with one lifetime pregnancy had significantly higher mean values 
in nearly all the observed lipids (except TG/HDL ratio) compared to mothers with two or 
more children (measured more than a decade after childbirth). Therefore, we aimed to 
further assess if lipid levels in these women were associated with their lifetime parity 
status, namely, the probability to have one child compared to having two or more 
children. We observed that women with LDL cholesterol greater than 4.57 mmol/l 
(highest quintile) and total cholesterol level greater than 5.70 mmol/l (two highest 
quintiles), measured more than a decade after first childbirth, had a higher probability of 
having only one child compared to women with the lowest quintile levels. 
Several studies have investigated women’s lipid trajectories after childbirth, however, the 
majority of studies looked at the effects in reference to nulliparity (127, 129, 130, 131). 
Although relevant from the aspect of total parity, this design has limited the ability of 
prior studies to identify the high-risk group of women having only one-child (as a feature 
of subfecundity). Some previous studies have reported no consistent association between 
parity and LDL/TG levels (130, 132), while others, with longer follow-up, have found an 
association between declining total cholesterol levels by parity (132) and associations 
between primiparity and levels of total cholesterol and LDL (131). A recent study 
reported the most pronounced adverse lipid changes in women following first birth, 
emphasizing the effect of a first pregnancy on women’s lipid profile (127).  
Our finding for non-HDL cholesterol further reinforces the role of lipids in relation to 
fertility. Since measurement of non-HDL cholesterol may be particularly useful in 
individuals with high TG levels (where Friedwald calculation for LDL cholesterol may 
have poorer performance) (94), the similarity of our findings for LDL and non-HDL 
cholesterol is suggestive of Friedwald’s calculation optimal performance. Given that 
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non-HDL cholesterol represents a sum of all ApoB-containing lipoprotein populations 
(95), its role in reproduction may involve ApoB related factors (10), while its predictive 
value for CVD risk is at least equivalent to or even more robust than LDL concentrations 
(95). 
The lack of association between post-pregnancy TG/HDL ratio in midlife women and the 
number of children could suggest that metabolic health might have more influence on 
fertility in women of younger reproductive age. In older women, metabolic factors might 
be overweighted by arterial remodelling (128) and other factors related to a still unclear 
role of HDL decline by higher parity (127, 128, 129). Although age-related factors are 
suggested to influence the change of HDL fractions in follicular fluid (11), several 
studies have reported the highest magnitude of the HDL drop associated with first birth, 
independent of maternal age (121, 125, 133). While HDL concentrations in the follicular 
fluid have been found to correlate with plasma levels (10), exactly how HDL content is 
influenced by pregnancy or may influence fertility potential is still unclear (11).  
 
Possible mechanisms behind the pregnancy-lipid status effect 
Possible explanations for the effects of pregnancy on lipid levels could include genetic 
differences or incipient dyslipidemias, which may induce excessive alterations in levels 
of lipoproteins associated with pregnancy (1, 130, 134). Progesterone during pregnancy 
may act to reset lipostat in the hypothalamus (134) and the placenta may convey an 
active role on maternal lipoprotein metabolism through fetal polymorphisms (inherited 
from the father) (135). It is possible, that in some women with preexisting dyslipidemia, 
placental influence (expressed from paternal inherited allele) will either partly 
compensate for or exaggerate maternal lipid profile (135). Interestingly, it has been 
observed that in several cases of familial lipoprotein lipase deficiency, TG levels during 
gestational follow up never reached concentrations higher than those observed during 
other periods of life (135). Hormonal changes accompanying pregnancy, related fat 
retention and/or redistribution and lifestyle/behavioural practices may also introduce 





Menopause. Besides pregnancy and childbirth, another important milestone in women’s 
life that can affect lipid profile is a menopausal transition (136). Estrogen deprivation in 
menopause may lead to increased total and LDL levels (68, 136). Due to a generally 
higher number of missing data for this variable, we examined the menopausal effect in a 
sensitivity analysis, including only women < 40 years of age. We observed that the 
results were only slightly attenuated from our main results, suggesting that menopause is 
not the major driver of the observed associations. 
 
Large sample size in this study allowed us to further explore the effects of various factors 
on the association between post-pregnant lipid levels and the number of children, such 
as: education, self-perceived health, family history of CVD, alcohol use and physical 
activity. Self-perceived health status is considered a strong predictor of circulatory 
diseases and mortality and may convey additional knowledge that is not captured by 
available clinical measurements (137). Indirectly, it may also provide useful insights 
about possible psychosocial factors, given that women with unfavourable psychosocial 
status are less likely to rate their health as good (137). Stratification by these factors 
showed the robustness of the associations while finding for physical activity is in 
agreement with reports of the modifiable effect of physical activity on lipid status (138). 
Similar to paper I, assessments of the duration of OC use, dietary intake or stress were 
not available. Non-fasting lipid status is a limitation, however, adjustments for time since 
last meal have not substantially changed our results. Additionally, the similarity of our 
findings for non-HDL and LDL cholesterol further supports this notion, given that non-
HDL levels are shown to be mostly unaffected by the recent food intake (95). Although 
detailed information on various environmental factors is unfortunately not registered in 
the MBRN, we tried to address this by using ‘year of first birth’ to account for potential 
cohort/generational/environmental effects (105). As for the possible effect of PCOS 
underreporting on our findings, one may speculate that underreporting of PCOS in our 
cohort might result in overestimation of the observed effect, however, it remains highly 
questionable whether this would substantially influence our results with the estimated 6% 
prevalence in the total sample (139). Extensive elaboration on this is further complicated 
by discrepancies in PCOS reporting, in part due to the use of various definitions of the 
syndrome and its subphenotypes, as well as differences between study cohorts and 
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ethnicities (139). Furthermore, we calculated E-values for both the main analyses and 
sensitivity analysis on women <40 years of age. The E-value calculations showed that an 
unmeasured confounder would need to have nearly four times as large an effect as 
maternal age (covariate with the strongest effect in the adjusted model, Exp (B)=1.13) 
and be associated with both the exposure and the outcome to completely explain away 
the observed associations (106). Although a strong unmeasured confounding factor could 
explain the association, a degree of confounding this strong seems unlikely, having in 
mind our generally stable results from various stratified analyses. We observed persistent 
higher ORs for both the strata of women who rate their health as good and those highly 
educated, which suggests that women’s health and education/socioeconomic status are 
not the main drivers of this association.  
 
5.2.3 Paper III 
We found that the risk of having one lifetime pregnancy was moderately increased for 
women with adverse outcomes however, largely dependant on perinatal survival of the 
infant. Women with PTD, SGA, PE or CS and a surviving child had moderately 
increased risk of having only one child compared to women without adverse outcome 
and no loss in the first pregnancy. However, having the same outcomes and losing the 
child significantly reduced the risk of having one lifetime pregnancy, irrespective of the 
outcome.  In line with previous studies (24, 32, 33), results potentiate ‘selective fertility’ 
as an important force in reproduction. 
 
We found increased risk of having one lifetime pregnancy in women with CS whose 
child survived and a markedly decreased risk if the child was lost. In line with several 
previous studies, this suggests that maternal choice plays an important role (12, 24, 29, 
140), while contrasts findings that report no association with reduced fertility (141, 142), 
or concluded physical consequences of CS on fecundity (27, 28).  
Similar to this, when we explored the effect of the combined variable (combining 2, 3 
and all the 4 outcomes), we observed that the increased risk of having one lifetime 




found decreased risk differences in a scenario with 3 combined outcomes (PE-PTD-CS 
and PTD-SGA-CS). Here, the higher risk of having one child remained irrespective of 
child loss, which suggests condition severity (26) and/or underlying health factors that 
might discourage or prevent future pregnancies.  
We further observed low dependency of preterm PE on perinatal survival (supported by 
non-significant interaction between PE in first birth and perinatal loss). Recent reports of 
3.6 % recurrence of PTD in women with previous early onset PE (<34 weeks) suggest 
these women’s predisposition to both PTD and PE from underlying conditions (30). It 
has been reported that the prevalence for the most chronic diseases increased since the 
1980s (143) and we explored the effect of diagnosed condition in a subanalysis by 
excluding women with asthma, chronic renal disease, cardiovascular disease and 
rheumatoid arthritis (in addition to excluding chronic hypertension and preexisting 
diabetes). We found that, for women with a surviving child, crude risks for having one 
child only slightly decreased from our main results for women with PE and CS, 
suggesting that maternal diagnosed condition could not explain away the observed 
association. For the woman whose infant died during the perinatal period, the crude risks 
for having one child remained unaltered in the same analysis. Less likelihood for a 
continuation of reproduction after a loss in preterm PE could reflect a possibility of 
residual confounding by subclinical or underlying health factors other than clinical 
conditions evaluated in our study (i.e. the possibility of genetic and/or metabolic 
conditions (120)). The traumatic experience of preterm birth combined with maternal 
ongoing health problems after PE could also contribute to women’s reluctance to 
conceive again (30). 
Our extensive registry-based study adds valuable information about women’s 
reproductive patterns during the lengthy period spanning over 4 decades. Additionally, 
we tried to quantify the degree to which a perinatal loss contributes to having a next 
pregnancy in a variety of clinical scenarios. From the aspect of methodology, we show 
that not accounting for perinatal loss when estimating the impact of pregnancy 
complications on future reproduction would be misleading. The MBRN, however, as the 
majority of registries, lack data on women’s family planning decisions, which is an 
acknowledged limitation of this study. Other limitations included lack of information on 
BMI, smoking, fertility treatments other than IVF and limited registration of ultrasound 
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dates (from 1999). Level of education may serve as a proxy for BMI (higher education 
correlates with lower BMI (115)) and adjustment for education may partially have 
accounted for BMI. A Danish study reported stronger effect of BMI on elective than on 
emergency CS (37). Residual confounding by CS indication cannot be excluded, 
however, exclusion of women with the aforementioned chronic conditions makes these 
less likely as an indication. A Norwegian study found the results consistent in both high 
and low risk cesarean delivery, implicating cesarean delivery as a reason for reduced 
fertility, and not the indications that lead to it (24).  Additionally, possible errors in 
gestational age estimates (last menstrual period vs. ultrasound-based) are not likely to be 
substantial in the MBRN (25). Validation studies showed good ascertainment of pre-
gestational diabetes and PE (91, 92), however, the possibility of under-reporting of type2 
diabetes and over-reporting of preexisting hypertension with spontaneous normalization 







Unfavourable pre-pregnant lipid levels were associated with having no and one lifetime 
pregnancy. These findings provide a possible biological underpinning for a joint 
mechanistic pathway for reduced fertility and cardiovascular conditions.  
 Paper II 
Mean lipid levels measured after childbirth in women with one child were significantly 
higher compared to mothers with two or more children and were associated with a higher 
probability of having only one child. The findings corroborate an association between 
serum lipid levels and one lifetime pregnancy (as a feature of subfecundity), emphasizing 
that these particular women may be a specific predetermined risk group for 
cardiovascular-related disease and death.  
Paper III 
Associations between adverse outcomes of pregnancy and the risk of having one lifetime 
pregnancy were strongly modified by child survival in the perinatal period. 
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7. Future implications 
Although examining parity in relation to maternal morbidity across time periods remains 
challenging due to the shift in women’s societal roles, still elevated CVD risk and mortality 
among one child mothers requires increased attention, from clinical, observational and 
experimental studies. Observational studies can contribute with important knowledge on 
factors associated with low parity (as a feature of subfertility). Findings from this thesis add 
biological underpinning to the observed association between one lifetime pregnancy and 
increased CVD mortality. In order to get an in-depth view, future observational studies 
should aim to investigate women sampled both before and after the first pregnancy. Large-
scale experimental and epigenetic studies are needed to explore the mechanisms underlying 
this association. 
Our findings contribute with the knowledge about women’s post-complication reproductive 
patterns during the lengthy period over 4 decades. More comprehensive understanding of the 
effect of adverse pregnancy events on future reproduction necessitates exploration of the 
specific factors such as social, cultural and health system differences that influence the event, 
which was beyond the scope of this thesis. The qualitative approach should be applied for 
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ABSTRACT
Objective To study prepregnancy serum lipid levels and 
the association with the number of children.
Design Prospective, population-based cohort.
Setting Linked data from the Cohort of Norway and the 
Medical Birth Registry of Norway.
Participants 2645 women giving birth to their first child 
during 1994–2003 (488 one-child mothers and 2157 
women with ≥2 births) and 1677 nulliparous women.
Main outcome measures ORs for no and one lifetime 
pregnancy (relative to ≥2 pregnancies) obtained by 
multinomial logistic regression, adjusted for age at 
examination, education, body mass index (BMI), smoking, 
time since last meal and oral contraceptive use.
Results Assessed in quintiles, higher prepregnant 
triglyceride (TG) and TG to high-density lipoprotein 
(TG:HDL-c) ratio levels were associated with increased 
risk of one lifetime pregnancy compared with having ≥2 
children. Compared with the highest quintile, women in the 
lowest quintile of HDL cholesterol levels had an increased 
risk of one lifetime pregnancy (OR 1.7, 95% CI 1.2 to 2.4), 
as were women with the highest low-density lipoprotein 
(LDL) cholesterol, TG and TG:HDL-c ratio quintiles 
(compared with the lowest) (OR 1.2, 95% CI 0.8 to 1.7; 
OR 2.2, 95% CI 1.5 to 3.2; and OR 2.2, 95% CI 1.5 to 3.2, 
respectively). Similar effects were found in women with 
BMI≥25 and the highest LDL and total cholesterol levels in 
risk of lifetime nulliparity.
Conclusion Women with unfavourable prepregnant lipid 
profile had higher risk of having no or only one child. These 
findings substantiate an association between prepregnant 
serum lipid levels and number of children. Previously 
observed associations between low parity and increased 
cardiovascular mortality may in part be due to pre-existing 
cardiovascular disease lipid risk factors.
INTRODUCTION 
Cardiovascular disease (CVD) is an important 
public health problem and remains the 
number one cause of death in women.1 
Reproductive history is important in eval-
uating health risks in women, as pregnancy 
may unmask a woman’s predisposition for 
CVD.1 Several studies have reported increased 
CVD mortality among women with no or only 
one lifetime pregnancy.2–4 Efforts to eluci-
date the association between the number of 
children and the risk of female CVD have 
been inconclusive.1 3 Proposed explanations 
are lifestyle risk factors associated with chil-
drearing,5 sex hormone fluctuations, protec-
tive effect of future pregnancies,3 lifestyle 
factors prior to conception such as elevated 
blood pressure and obesity,6 as well as meta-
bolic irregularities triggered by gestation.1 
Detection of high-density lipoprotein (HDL) 
cholesterol and apolipoprotein B (ApoB) in 
follicular fluid from oocytes7 8 suggests a rela-
tion between lipids and female reproductive 
function. More recent studies have reported 
associations between lipids and fertility in 
both sexes.9 Low parity (as a feature of subfe-
cundity) and cardiovascular events may share 
common pathophysiological mechanisms.10 
While the role of serum lipids in cardiomet-
abolic health is well established, showing 
low HDL and high triglycerides (TGs) to 
be strong predictors of CVD,11 their role in 
reproduction is uncertain. It is also uncertain 
whether women with no or one lifetime preg-
nancy have a higher CVD risk to begin with, 
or whether future pregnancies may reduce 
the CVD risk.
Strengths and limitations of this study
 ► This is a large population-based study with data col-
lected before pregnancy.
 ► Linkage with the Medical Birth Registry of Norway 
provided complete registration of total reproduction.
 ► Limitations include lack of data on family planning, 
dietary intake, duration of oral contraceptive use, 
APOE genotype, low-grade inflammation and thyroid 
status.
 ► Non-fasting lipid measurements were used; howev-
er, adjustments in our analyses for time since last 
meal did not change the results.
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We pursued this question by exploring the extent to 
which prepregnant serum lipid levels of total, HDL and 
low-density lipoprotein (LDL) cholesterol, TG and TG:H-
DL-c ratio are associated with having no and one lifetime 
pregnancy.
MATERIALS AND METHODS
Study design and population
We used linked data from the Cohort of Norway (CONOR) 
and the Medical Birth Registry of Norway (MBRN). 
CONOR is a population-based collection of health data 
and blood samples provided by participants older than 
20 years of age residing in several different regions in 
Norway during 1994–2003.12 Our subset included women 
with no children at the time of examination with stan-
dardised measurements of height, weight and non-fasting 
lipids levels. Lifestyle factors were obtained through 
an extensive questionnaire that collected self-reported 
information on smoking, oral contraceptive (OC) use, 
self-reported status on receipt of social security benefits, 
attained level of education and various lifestyle factors.12 
Education in Norway consists of primary school (7 years), 
lower secondary school (3 years), upper secondary school 
(3 years) and higher education. The first 10 years are 
obligatory.
The MBRN has since 1967 recorded data on all deliv-
eries in the country after 16th week of gestation.13 Based 
on mandatory notification, midwives and doctors report 
information using standard forms throughout preg-
nancy and at the time of delivery. The registry includes 
demographic information, mother’s health prior and 
during pregnancy, complications in pregnancy and 
perinatal outcome. Using the unique national identi-
fication number given to all Norwegian citizens, each 
woman was linked to all her subsequent births (if any) 
after participating in CONOR. Women reporting no chil-
dren in CONOR at the time of examination and with no 
valid records in the MBRN were considered having no 
pregnancies.
Women with baseline assessment of lifestyle factors in 
CONOR were linked to the MBRN. We defined one-child 
mothers as women being 6 years out from their first preg-
nancy and with no additional births registered in the 
MBRN.
Preconception measurements
Non-fasting blood samples were analysed on a Hitachi 
911 Auto Analyzer (Hitachi, Mito, Japan).12 Applied 
reagents were from Boehringer Mannheim (Mannheim, 
Germany). Serum concentrations of total cholesterol, 
HDL cholesterol and TG were analysed subsequent to 
sampling. The total cholesterol, HDL cholesterol levels 
and TGs were measured by an enzymatic method. The 
day-to-day coefficients of variation were 2.4% and 0.7%–
1.3% for total cholesterol, HDL cholesterol and TG, 
respectively. To calculate LDL, we used the Friedewald 
formula14: total serum cholesterol minus HDL cholesterol 
minus one-fifth of the TG concentration. LDL choles-
terol levels were calculated only for participants with 
TG concentrations below 4.5 mmol/L.6 14 Accordingly, 
the TG:HDL-c ratio was expressed as mmol/L.
Trained personnel measured the height and weight, 
with the participants wearing light clothes and no shoes; 
measurements were taken as follows: height to the nearest 
1.0 cm and weight to the nearest 0.5 kg. Body mass index 
(BMI) was calculated as weight in kilogram/(height in 
metres)2.
Patients and public involvement
Patients or the public were not directly involved in this 
study. The detailed explanation of the recruitment 
process and the obtainment of written informed consent 
for CONOR were provided elsewhere.12
Statistical analyses
The characteristics of the analysed women were presented 
as means with SD for continuous data and as number with 
percentages for categorical data. Differences between 
nulliparous women, one-child mothers and mothers 
with two or more children, as well as prepregnant health 
status, were analysed by χ2 tests and t-tests where appro-
priate. Linear associations across prepregnant lipid levels 
(in quintiles) for no and one lifetime pregnancy were 
assessed by p values for trend. ORs of no and one life-
time pregnancy by lipid levels and TG:HDL-c ratio, when 
compared with women with two or more pregnancies, 
were calculated using multinomial logistic regression and 
adjusted for mother’s age at examination, level of educa-
tion (categorised in <11 years and >11 years of educa-
tion), smoking (current smoker: yes, no), time since last 
meal, OC use (now, previously, never) and BMI (linear 
term). To extend each woman’s likelihood of completing 
her birth record, we separately examined women who 
were 7 years out from their first pregnancy. About 95% of 
Norwegian women will complete their second pregnancy 
within 7 years.4 To test the effect of (prepregnant) BMI, 
we stratified the main analyses by BMI (<25 and ≥25). To 
avoid influence from age at first delivery on the number 
of children, we excluded women older than 34 years at 
the time of first delivery in a subanalysis. Additionally, 
we performed sensitivity analyses including only mothers 
who were 22–30 years old at the time of first delivery. 
Using presence of a partner (ever) as a proxy for exposure 
to pregnancy among nulliparous women, we performed 
logistic regression in a subanalysis (nulliparous vs women 
with ≥2 births) including only women with a reported 
partner (ever). All analyses were performed using the 
Statistical Package for Social Sciences (SPSS V.22.0 and 
V.23.0).
RESULTS
There were 4743 women with baseline assessment of life-
style factors in CONOR (1994–2003) that were linked 
to the MBRN. We excluded 421 women with pregnancy 
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at the time of examination (n=139), unsure pregnancy 
status (n=157) and missing lipid assessments (n=125). 
Thus, 4322 women were included in the analyses (1677 
nulliparous, 488 one-child mothers and 2157 women 
with ≥2 births; see figure 1). Subanalyses included only 
women with reported partners (228 nulliparous and 216 
mothers with ≥2 births).
The characteristics of the included women are given 
in table 1. Nulliparous women were older at the time of 
examination, had higher BMI and were more frequent 
smokers compared with women with two or more births. 
A higher proportion of nulliparous women had >11 years 
of education. One-child mothers had higher mean age 
both at examination and at delivery (29.5 vs 26.7 and 32.3 
vs 29.9, respectively), were more often smokers and had 
lower education than mothers with ≥2 births. The mean 
BMI prior to pregnancy was higher in one-child mothers 
(24.2 vs 23.5), whereas the mean years from examination 
to first delivery were similar for the two groups. Women 
with no and one child were less frequent users of OCs at 
the time of examination compared with mothers with ≥2 
births (27.4%, 34.6% and 48.9%, respectively).
The proportion of diabetes at first delivery in one-child 
mothers was higher than in women with two or more 
Figure 1 Norwegian women examined in the Cohort of Norway (CONOR) before conception of their first pregnancy and with 
linked data from the Medical Birth Registry of Norway (MBRN).
Table 1 Characteristics of 4322 Norwegian women in the Cohort of Norway, 1994–2003, with no, 1 or ≥2 children
Mean values 1677 no child 488 one child 2157 ≥2 children
Age (SD) at examination 30.5 (2.1) 29.5 (5.2) 26.7 (4.0)
Age (SD) at first delivery – 32.3 (4.9) 29.9 (3.8)
Years (SD) from examination to first pregnancy – 3.7 (2.1) 4.1 (2.3)
BMI (SD) at examination* 24.8 (5.1) 24.2 (4.5) 23.5 (3.4)
OC use*
   Now 455 (27.4) 168 (34.6) 1047 (48.9) 
   Previously  724 (43.5) 239 (49.2) 779 (36.4) 
   Never 484 (29.1) 79 (16.3) 317 (14.8) 
Smoking at examination*
  Yes 537 (32.2) 182 (37.4) 462 (21.5)
  No 1132 (67.8) 304 (62.6) 1685 (78.5)
Education*
  <11 years 312 (18.8) 127 (26.3) 300 (14.1)
  ≥11 years 1344 (81.2) 356 (73.7) 1834 (85.9)
Values are numbers (percentages) unless stated otherwise.
*Missing data on smoking: 8 nulliparous, 2 one-child mothers and 10 women with ≥2 children; BMI, 10 nulliparous; education, 21 nulliparous, 
5 one-child mothers and 23 women with ≥2 children; OC use: 4 nulliparous, 2 one-child mothers and 14 women with ≥2 children.
BMI, body mass index; OC, oral contraceptive.
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births (1.4% vs 0.9%, p=0.30). Polycystic ovary syndrome 
(PCOS) was rare and we only had three cases in our mate-
rial. A significantly higher number of one-child mothers 
had in vitro fertilisation (IVF) in their first pregnancy 
(7.2% vs 2.6% in women with ≥2 births; p<0.001) (data 
not shown). This latter finding remained after excluding 
mothers older than 34 years at first delivery.
ORs with 95% CIs for no and one lifetime pregnancy 
(vs ≥2 lifetime pregnancies) by lipid levels (in quin-
tiles) are presented in table 2 and figure 2. Significant 
trends in ORs for one lifetime pregnancy across TG and 
TG:HDL-c ratio quintiles were observed (p trend=0.01). 
The OR for having one lifetime pregnancy for women 
with the highest TG quintile compared with the lowest 
quintile was 2.2 (95% CI 1.5 to 3.2). The ORs for having 
one lifetime pregnancy for women with TG:HDL-c ratio 
levels in the two highest quintiles were 1.7 (95% CI 1.2 to 
2.5) and 2.2 (95% CI 1.5 to 3.2), respectively, compared 
with the lowest quintile. There were no significant trends 
for LDL cholesterol, total cholesterol or HDL choles-
terol, although the ORs of one lifetime pregnancy for 
the lowest HDL quintile were 1.7 (95% CI 1.2 to 2.4) 
and for the highest LDL quintile 1.2 (95% CI 0.8 to 
1.7). We found no increased risk of being nulliparous by 
serum lipid levels except for the highest LDL and total 
cholesterol levels, and these estimates were not persua-
sive (OR 1.2 (95% CI 0.9 to 1.6) and 1.2 (95% CI 0.9 
to 1.5), respectively). Truncation of data to extend the 
time for each woman to complete her birth record (to 7 
years) did not appreciably alter the results, neither did 
Table 2 ORs with 95% CI for no and one lifetime pregnancy (reference: women with ≥2 pregnancies) by prepregnant lipid 
quintiles in 4322 women in the Cohort of Norway, 1994–2003
Lipid 
quintiles* in 




N OR (95% CI) OR (95% CI) P for trend
LDL cholesterol† 0.82
  <2.42 449 (56.9) 261 (33.0) 80 (10.1) 790 1.0 (reference) 1.0 (reference)
  2.43–2.84 433 (52.3) 309 (37.4) 85 (10.3) 827 1.1 (0.9 to 1.4) 1.0 (0.7 to 1.4)
  2.85–3.24 454 (52.2) 325 (37.4) 90 (10.4) 869 1.0 (0.8 to 1.3) 0.9 (0.7 to 1.3)
  3.25–3.76 426 (48.0) 353 (39.8) 108 (12.2) 887 1.1 (0.7 to 1.2) 1.1 (0.8 to 1.6)
  >3.77 391 (41.9) 421 (45.1) 121 (13.0) 933 1.2 (0.7 to 1.1) 1.2 (0.8 to 1.7)
Total cholesterol 0.26
  <4.19 432 (55.0) 259 (33.0) 94 (12.0) 785 1.0 (reference) 1.0 (reference)
  4.20–4.61 456 (54.6) 304 (36.4) 75 (9.0) 835 1.2 (0.9 to 1.5) 0.8 (0.5 to 1.1)
  4.62–5.0 434 (52.2) 306 (36.8) 91 (11.0) 831 1.0 (0.8 to 1.3) 0.9 (0.6 to 1.2)
  5.1–5.63 442 (45.7) 415 (43.0) 109 (11.3) 966 1.3 (1.0 to 1.7) 1.0 (0.7 to 1.4)
  >5.64 393 (43.4) 393 (43.4) 119 (13.1) 905 1.2 (0.9 to 1.6) 1.0 (0.7 to 1.4)
TG 0.01
  <0.66 429 (48.6) 372 (42.2) 81 (9.2) 882 1.0 (reference) 1.0 (reference)
  0.67–0.86 447 (49.8) 350 (39.0) 100 (11.1) 897 0.9 (0.7 to 1.1) 1.2 (0.8 to 1.7)
  0.87–1.09 455 (54.4) 294 (35.1) 88 (10.5) 837 0.9 (0.7 to 1.2) 1.3 (0.9 to 1.9)
  1.10–1.45 452 (53.6) 303 (35.9) 88 (10.4) 843 1.0 (0.8 to 1.3) 1.4 (1.0 to 2.0)
  >1.46 373 (43.3) 358 (41.6) 130 (15.1) 861 1.1 (0.9 to 1.5) 2.2 (1.5 to 3.2)
HDL cholesterol 0.18
  <1.20 326 (47.5) 263 (38.3) 97 (14.1) 686 1.0 (0.8 to 1.3) 1.7 (1.2 to 2.4)
  1.21–1.40 271 (44.7) 260 (42.9) 75 (12.4) 606 1.0 (0.8 to 1.2) 1.2 (0.8 to 1.7)
  1.41–1.60 634 (53.0) 431 (36.1) 130 (10.9) 1195 1.0 (0.7 to 1.3) 1.2 (0.9 to 1.6)
  1.61–1.84 443 (49.7) 356 (40.0) 92 (10.3) 891 0.9 (0.7 to 1.2) 1.1 (0.8 to 1.5)
  >1.85 483 (51.2) 367 (38.9) 94 (10.0) 944 1.0 (reference) 1.0 (reference)
The estimates were obtained by multinomial logistic regression and adjusted for age at examination, educational level, smoking, time since 
last meal, oral contraceptive use and body mass index (linear term). 
Number of women: with ≥2 children (n, reference group), nulliparous women (na), one-child mothers (nb) and total number of women within 
the category (N).
*Quintiles calculated on a total sample prior to pregnancy.
†Missing data within lipids on 16 cases of LDL and 2 cases of TG.
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exclusion of women older than 34 years at the time of first 
delivery nor the additional restriction of our analyses to 
mothers aged 22–30 years at first pregnancy. The similar 
effects of prepregnant lipids as in one-child mothers were 
observed when subanalyses (nulliparous vs ≥2 births) 
were performed on women who had a partner (as a proxy 
for ever being exposed to pregnancy). For women with 
partner, the risk of having no children was increased 
among the women in the highest quintiles of TG and 
TG:HDL-c ratio (compared with the lowest quintiles) and 
also for those in the lowest HDL quintile (compared with 
the highest) (OR 1.9, 95% CI 0.9 to 4.2; OR 2.0, 95% CI 
1.0 to 4.1; and OR 1.6, 95% CI 0.7 to 3.6, respectively).
Stratified analyses by BMI are presented in table 3. In 
women with BMI≥25 there were significant trends in ORs 
of having no children or one child across increasing levels 
of prepregnant total cholesterol, TG and TG:HDL-c ratio 
quintiles (p trend=0.04 and <0.001, respectively). The 
adjusted ORs of one lifetime pregnancy for women with 
BMI≥25 and TG levels in the two highest quintiles were 
2.1 (95% CI 0.9 to 4.8) and 3.5 (95% CI 1.6 to 7.4), and 
for the two highest TG:HDL-c ratio quintiles 3.1 (95% 
CI 1.3 to 7.4) and 4.3 (95% CI 1.9 to 10.0) compared 
with women in the lowest respective quintile. The risk of 
one lifetime pregnancy was also significantly increased 
for women with BMI≥25 and the highest LDL and total 
cholesterol, as well as the lowest HDL quintiles (OR 1.8 
(95% CI 0.8 to 3.8),  1.2 (95% CI 0.6 to 2.4) and 2.6 (95% 
CI 1.3 to 5.3), respectively). Similarly, the ORs of having 
no pregnancy (in women with BMI≥25) were 1.7 (95% CI 
1.0 to 3.0), 2.8 (95% CI 1.7 to 4.7) and 3.6 (95% CI 2.1 to 
6.1) for women with the highest LDL, TG and TG:HDL-c 
ratio quintiles, respectively, compared with women with 
the lowest quintile. An increased risk of having no chil-
dren was also found for the overweight and obese women 
with the lowest HDL quintile (OR 1.9, 95% CI 1.2 to 3.0). 
Unlike in one-child mothers, the risk of having no preg-
nancy among overweight and obese women with higher 
total cholesterol levels only slightly changed from the 
main results. In women with prepregnant BMI<25, there 
were significant trends in the risk of having one lifetime 
pregnancy across increasing levels of prepregnant TG (p 
trend=0.04), TG:HDL-c ratio (p trend=0.04) and HDL 
quintiles (p trend=0.05). There were increased risks of 
one lifetime pregnancy in the highest TG quintile (OR 
1.9, 95% CI 1.2 to 3.0) and the two highest TG:HDL-c 
ratio quintiles (OR 1.6, 95% CI 1.0 to 2.4; and OR 1.8, 
95% CI 1.2 to 2.8, respectively), as well as the lowest HDL 
quintile (OR 1.7, 95% CI 1.1 to 2.6). The risks of no and 
one lifetime pregnancy with higher LDL and total choles-
terol levels only slightly changed compared with our main 
results.
DISCUSSION
Prepregnant lipid levels were associated with having one 
lifetime pregnancy. Women with high levels of LDL, TG 
and TG:HDL-c ratio, as well as low HDL levels, measured 
years before conception, were at increased risk of having 
only one lifetime pregnancy. High levels of LDL and 
total cholesterol were associated with having no children, 
while in overweight and obese women this was true for all 
the lipids examined.
These findings provide a possible biological underpin-
ning for a joint mechanistic pathway for reduced fertility 
and cardiovascular conditions.10 Our study suggests that 
the previously observed association between low parity 
and increased CVD risk may be confounded by pre-ex-
isting adverse lipid levels. This does not support the 
hypothesis that having additional pregnancies reduces 
Figure 2 ORs with 95% CI for no and one lifetime pregnancy (reference: women with ≥2 pregnancies) by TG:HDL-c ratio 
quintiles in 4322 women in the Cohort of Norway, 1994–2003. The estimates were obtained by multinomial logistic regression 
and adjusted for age at examination, educational level, smoking, time since last meal, oral contraceptive use and body mass 
index (linear term). TG:HDL-c, triglycerides to high-density lipoprotein ratio. 
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CVD risk.3 Rather, unfavourable lipid profiles may be 
related to both subfertility and later CVD.
There is a lack of studies evaluating the relation between 
preconception lipid levels and fertility in women. The 
LIFE (Longitudinal Investigation of Fertility and the Envi-
ronment) study found concentrations of free cholesterol 
to be associated with fecundity in both sexes.9 In contrast 
to our study, TGs and total cholesterol were not found 
to be significant in individual and couple-based adjusted 
models (as well as two other measured lipid components: 
phospholipids and total lipids); however, the authors used 
a different study design and lipid measurement methods. 
In accordance with our findings is the Framingham Heart 
Study, which detected a trend towards TG elevation and 
lower HDL serum levels among women with self-reported 
infertility (as not achieving pregnancy for ≥1 year).15 
The presence of HDL cholesterol and ApoB in follicular 
fluid from human oocytes suggests that these lipids play 
a direct role in reproduction.7 8 16 Previous animal studies 
have reported an association between dyslipidaemia and 
infertility.17 Posed explanations have been that abnormal-
ities in HDL metabolism including change in structure, 
concentration or function compromise female fertility.7 8 16 
It has been suggested that genetic polymorphisms that 
alter function in proteins engaged in cholesterol metab-
olism may affect human fertility.18 19 One of the possible 
molecular mechanisms could be through a mediating 
role of HDL on paraoxonase 1 activity. Paraoxonase is 
an HDL-associated enzyme that inhibits LDL oxidation, 
and thus protects cells from oxidative stress.20 Its stability 
and binding affinity are strongly influenced by changes 
in shape and size of HDL particles.21 These changes may 
lead to decreased antioxidative capacity and consecutively 
oxidative stress. Oxidative stress is associated with adverse 
cardiovascular and fertility outcomes, including athero-
sclerosis, PCOS, pre-eclampsia, endometriosis and infer-
tility.19 22 A recent study in women of reproductive age with 
upper normal ranges of thyroid-stimulating hormone has 
suggested a direct link between unfavourable lipid profile 
and increased oxidative membrane damage.23
Recent insights suggest TG:HDL-c ratio to be a reli-
able marker of insulin resistance and atherogenicity,24 
highlighting its ability to identify insulin resistance in 
apparently healthy individuals.25 Observed higher levels 
of TG:HDL-c ratio in our study are indicative of possible 
pre-existing metabolic risk factors among women with 
one lifetime pregnancy, as well as a subpopulation of 
nulliparous women (overweight, obese and with reported 
partners—as a proxy for exposed to pregnancy). This is 
also consistent with increasing rates of infertility in both 
sexes among population with metabolic syndrome.9 The 
higher proportion of diabetes in this group of women 
further supports this notion. In agreement, the Japan 
Nurses’ Health Study reported a significant increase in 
the risk of diabetes in young nulliparous women (<45 
years of age) with ovarian infertility.26 Accordingly, the 
Framingham Heart Study found infertile premenopausal 
women to have increased odds of diabetes and obesity.15 
Given the accompanying metabolic irregularities among 
major causes of female infertility,15 27 substantially higher 
proportion of IVF treatment among one-child mothers 
indirectly supports metabolic implications. The latter 
finding remains after exclusion of women older than 34 
years at the time of first delivery.
Dyslipidaemia is associated with PCOS.28–30 However, 
we only identified three women with PCOS in our study 
sample. Thus, the presence of subclinical forms or 
under-reporting may be present.
In accordance with the literature,27 31 the risk of having 
no and only one child showed strong effects in over-
weight and obese women (BMI ≥25) in stratified analyses 
(table 3). Nevertheless, the higher risk of having only one 
child remained in normal-weight women (BMI<25) with 
the lowest HDL quintile and the highest TG and TG:H-
DL-c ratio quintiles. These findings mirror observations 
from the literature of metabolic irregularities among 
normal-weight women as an independent risk factor for 
future fertility impairments.32 33 The LIFE study reported 
both female and male lipid concentrations to affect 
fecundity, irrespective of their BMI.9
Compared with women with two or more pregnancies, 
total cholesterol levels above clinically recommended 
range were associated with risk of having no children, 
irrespective of BMI. The LIFE study reported a higher 
percentage of women with a history of irregular menstrual 
cycles in the highest quartile of free cholesterol.9 The 
Japan Nurses’ Health Study found women with ovarian 
infertility to be at high risk of hypercholesterolaemia.26 
In our study, total cholesterol levels were not associated 
with the risk of having one lifetime pregnancy, except 
among overweight and obese women. This could suggest 
that total cholesterol levels play varied roles in different 
subfecundity or infertility subtypes. In addition, nullipa-
rous women in our study were older at examination and 
had higher BMI. Both age and obesity are associated with 
systemic oxidative stress.19 22 It is possible that in such 
physiological environment, clinically abnormal levels 
of certain lipids might activate additional pathological 
processes that adversely affect reproductive function.28
In our study, women with one lifetime pregnancy 
had poorer lifestyle factors (BMI, smoking), were older 
and less educated. The lower mean education among 
one-child mothers is in agreement with a Nordic demo-
graphic study,34 which shows that later onset of child-
bearing is related to a lower number of children finally 
born in women with low education. Given that educa-
tional level and occupation are key indicators of socioeco-
nomic status,35 observed lower parity among women with 
low education could also reflect unfavourable socioeco-
nomic position as a limiting factor to further pregnancies. 
However, a study exploring age at first birth, parity and 
postreproductive mortality suggests that late childbearing 
in itself may be a signal of pre-existing poor health of a 
woman.36
The observed risk differences between nulliparous 
women and one-child mothers in our main results 
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(figure 2, table 2) could be explained by the hetero-
geneity of causes for childlessness among nulliparous 
women in this cohort. The risk may, therefore, be diluted 
by low-risk groups of women who are voluntarily child-
less37 or have not been exposed to pregnancy (ever). 
Given the lack of information on women’s reproductive 
planning in our data, we tried to address this in a subanal-
ysis including only women with reported partner (ever) as 
a proxy for being exposed to pregnancy. Here we found 
that the results for nulliparous women were similar to our 
main results for one-child mothers. Women with reported 
partner had higher risk of having no children (compared 
with partnered women with ≥2 births) if their TG and 
TG:HDL-c ratio levels were in the highest quintiles and 
HDL in the lowest quintile (OR 1.9, 95% CI 0.9 to 4.2; 
OR 2.0, 95% CI 1.0 to 4.1; and OR 1.6, 95% CI 0.7 to 3.6, 
respectively). These findings support the role of serum 
lipids in lifetime nulliparity among women with partners.
Strengths and limitations
Our subset of women was from a large population-based 
health study with prepregnant health data. Linked data from 
the MBRN provided complete registration of total repro-
duction. The prospective design minimised the potential for 
bias. A weakness is that blood sampling was performed in 
a non-fasting state. Studies show that TG levels are sensitive 
to recent food intake, while cholesterol levels seem to be less 
affected.38 We addressed this by adjusting our analyses for 
time since last meal and the main results were unchanged, 
suggesting that non-fasting lipids are not likely to introduce 
a systematic bias. Non-fasting lipids have successfully been 
used in lipid and CVD research.9 39 40
The study lacked data on apolipoprotein E genotype, 
CRP (C-reactive protein) and thyroid tests/thyroid 
antibodies, factors that all are found to affect female 
fertility.23 41 No assessments of duration or temporal prox-
imity of OC use, dietary intake or stress were available; 
therefore, unmeasured confounding cannot be ruled out. 
Smoking adversely influences female fertility,42 with most 
of its effects attributed to HDL cholesterol decrease.43 
We accounted for this in our analyses; however, smoking 
status of participants was only available at enrolment. The 
ethnic homogeneity of the included women may reduce 
the generalisability of our findings.
Unfavourable prepregnant lipid levels were associated 
with having no and one lifetime pregnancy. Women’s 
metabolic homeostasis is important for reproduction 
and also has cardiometabolic implications.32 44 Pre-ex-
isting poor lipid and metabolic profiles could represent 
one of the possible linkages between previously observed 
reduced fertility and later CVD.
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Introduction: With	 increasing	 cesarean	 section	 rates,	 adverse	 pregnancy	 outcomes	
such	 as	 preterm	delivery	 and	 small‐for‐gestational‐age	 continue	 to	 be	 public	 health	




pregnancy	 outcomes	 on	 future	 reproduction	 may	 lead	 to	 erroneous	 conclusions.	
However,	few	studies	have	explored	to	what	degree	a	perinatal	loss	contributes	to	hav-
ing	a	next	pregnancy	in	various	adverse	pregnancy	outcomes.
















0.63	 [0.59‐0.68],	 small‐for‐gestational‐age:	 0.57	 [0.51‐0.63],	 preeclampsia:	 0.69	
[0.59‐0.80],	cesarean	section:	0.67	[0.56‐0.79]),	compared	with	women	with	no	peri-












delivery	 (PTD)	 and	 small‐for‐gestational‐age	 (SGA)	 continue	 to	 be	
public	 health	 challenges,	 despite	 health	 system	 improvements.6 
Besides	having	high	co‐occurrence	and	interrelation,6 it is suggested 
that	 these	outcomes,	 along	with	preeclampsia	 (PE),	 are	associated	
with	 reduced	 subsequent	 fertility.2,7,8	On	 the	other	hand,	 the	 loss	




of	 pregnancy	 outcomes	 on	 future	 reproduction	may	 lead	 to	 erro-
neous conclusions.10	However,	 few	studies	have	explored	 to	what	
degree	 a	 perinatal	 loss	 contributes	 to	 having	 a	 next	 pregnancy	 in	

















As	 part	 of	 the	 preventive	 health	 program	 of	 pregnancy	 in	
Norway,	 all	women	were	 examined	 and	 interviewed	by	 a	midwife	
and/or	 a	 general	 practitioner	 on	 a	 regular	 basis	 throughout	 preg-
nancy.	 Information	 on	 medical	 history,	 body	 measures,	 previous	
births,	and	previous	and	current	complications	were	collected.	The	
obtained	information	was	regularly	updated	on	the	antenatal	chart	
during	health	visits.	At	 the	 time	of	delivery,	 the	antenatal	 chart	 is	

















(HELLP),	 in	 accordance	 with	 recommendations	 by	 the	 Norwegian	
Society	of	Gynecology	and	Obstetrics.13	Previous	validation	studies	
of	PE	 in	 the	MBRN	showed	 satisfactory	positive	predictive	 value,	





























analysis by perinatal loss.
2.2 | Characteristics of the included women are 
presented as numbers and proportions













pregnancies,3	 we	 included	 only	women	with	 singleton	 first	 births	
in	our	analyses.	In	subanalyses,	we	excluded	women	with	preexist-
ing	diabetes,	previous	hypertension,	 in	vitro‐fertilized	pregnancies	
(from	 1988)	 and	women	with	 chronic	 conditions	 (asthma,	 chronic	
renal	 disease,	 cardiovascular	 disease	 and	 rheumatoid	 arthritis),	
and	performed	stratified	analyses	on	marital/cohabitant	 status	 (to	
examine	the	effect	of	having	a	partner).	We	truncated	the	data	to	






















We	 identified	 882	803	women	 giving	 birth	 to	 their	 first	 singleton	
infant	 (≥22	weeks)	 between	1967	 and	2007.	Of	 all	women,	 16.1%	





















































one	 lifetime	pregnancy	when	 the	child	 survived	 the	perinatal	pe-
riod	was	significantly	increased	for	all	the	examined	outcomes:	1.21	
(1.19‐1.22);	 1.13	 (1.12‐1.15);	 1.09	 (1.07‐1.11)	 and	1.24	 (1.23‐1.25)	

















nancy	(P	=	0.001,	P = 0.005 and P	<	0.001,	respectively).	We	found	no	
significant	interaction	between	PE	in	first	birth	and	loss	(P	=	0.47).






CI	1.63‐1.68),	whereas	 for	women	with	no	 loss,	 results	 remained	
unaltered.	 Stratification	 by	 marital/cohabitating	 status	 showed	 a	
decrease	 in	 RR	 of	 having	 one	 lifetime	 pregnancy	 among	 unmar-
ried	 and	 single	 women	 with	 observed	 complications,	 implicating	
an	 effect	 of	 having	 a	 long‐term	 partner	 (Supporting	 Information	
Table	S1).	 In	our	examination	of	 changes	 in	maternal	 characteris-




number	of	 single	women	was	accompanied	by	a	7.6%	 increase	 in	
education	level	(Supporting	Information	Table	S2).







Women	 with	 PTD,	 SGA,	 PE	 or	 CS	 and	 one	 surviving	 child	 had	 a	
higher	risk	of	having	only	one	child	compared	with	women	without	
TA B L E  2  Crude	and	adjusted	relative	risks	(RR)	with	95%	confidence	interval	(CI)	for	having	one	lifetime	pregnancy	in	882	803	women	by	
preterm	delivery	(PTD),	small‐for‐gestational‐age	(SGA),	preeclampsia	(PE)	and	cesarean	section	(CS)	with	and	without	a	perinatal	loss	in	first	
pregnancy	(Medical	Birth	Registry	of	Norway	1967‐2007)
Outcomes N (total) One‐child mothers, n (%) Crude RR, 95% CI Adjusted RR, 95% CI
PTD	and	no	loss 47	984 10	326	(21.51) 1.35	(1.33‐1.38) 1.21	(1.19‐1.22)
No	PTD	and	loss 3782 269	(7.11) 0.45	(0.40‐0.50) 0.42	(0.37‐0.47)
PTD	and	loss 6196 635	(10.29) 0.64	(0.60‐0.69) 0.63	(0.59‐0.68)
No	PTD	and	no	loss 824	841 131	148	(15.89) 1.00	(Reference) 1.00	(Reference)
SGA	and	no	loss 103	714 19	320	(18.63) 1.17	(1.16‐1.19) 1.13	(1.12‐1.15)
No	SGA	and	loss 6675 593	(8.90) 0.56	(0.52‐0.60) 0.54	(0.50‐0.58)
SGA	and	loss 3303 311	(9.41) 0.59	(0.53‐0.66) 0.57	(0.51‐0.63)
No	SGA	no	loss 769 111 122	154	(15.90) 1.00	(Reference) 1.00	(Reference)
PE	and	no	loss 36 825 7006	(19.02) 1.18	(1.16‐1.20) 1.09	(1.07‐1.11)
No	PE	and	loss 9142 799	(8.74) 0.54	(0.50‐0.58) 0.52	(0.49‐0.56)
PE	and	loss 836 105	(12.56) 0.78	(0.66‐0.91) 0.69	(0.59‐0.80)
No	PE	no	loss 836 000 134	468	(16.08) 1.00	(Reference) 1.00	(Reference)
CS and no loss 92 161 23	439	(25.43) 1.68	(1.66‐1.70) 1.24	(1.23‐1.25)
No	CS	and	loss 9059 793	(8.75) 0.58	(0.54‐0.62) 0.55	(0.52‐0.59)
CS and loss 919 111	(12.08) 0.80	(0.67‐0.95) 0.67	(0.56‐0.79)
No	CS	no	loss 780	664 118	035	(15.12) 1.00	(Reference) 1.00	(Reference)
Women	were	followed	for	the	occurrence	of	a	second	pregnancy	until	2014.	Estimates	were	adjusted	for	maternal	age	at	first	birth,	education,	and	year	
of	childbirth.
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adverse	outcome	and	no	loss	in	the	first	pregnancy.	However,	hav-



















in	delivery.	 Increase	 in	one	 lifetime	pregnancy	risk	when	PTD	was	
followed	by	SGA	 (Figure	1,	PTD‐SGA)	 is	 in	 line	with	 reports	of	 in-
creased	severity	when	these	exposures	are	combined.6
The	RR	 for	having	one	 lifetime	pregnancy	 in	women	with	PE	
(and	 a	 surviving	 child)	was	marginally	 increased,	 consistent	with	
studies	that	have	reported	a	lower	birth	rate	after	PE	in	first	preg-
nancy.9,18,19	A	recent	study	suggested	that	women	who	developed	
PE	 are	 more	 likely	 to	 be	 older,	 have	 comorbidities	 or	 assisted	
reproductive treatment.19	In	our	study,	the	risk	of	having	one	life-







mirrors	 the	 findings	 that	 distinguish	 two	 conditions	 of	 PE:	 term	
and preterm.17,20	The	increase	could	be	due	to	more	severe	clinical	
presentations	compared	with	term	PE,	resulting	in	preterm	deliv-
ery	and	related	fetal	complications.18,19 We observed low depen-
dency	of	preterm	PE	on	perinatal	 survival	 (further	 supported	by	
nonsignificant	interaction	between	PE	in	first	birth	and	perinatal	
loss).	Recent	reports	of	a	3.6%	recurrence	of	PTD	in	women	with	
previous	 early	 onset	 PE	 (<34	weeks)	 suggest	 that	 these	 women	
have	a	predisposition	 to	both	PTD	and	PE	 from	underlying	 con-





increases	 fetal	 and	maternal	 morbidities,	 and	 is	 associated	with	
chronic	 factors.18	 The	psychosocial	 burden	of	preterm	birth	 and	
maternal	health	problems	after	PE	could	also	contribute	to	wom-
en's reluctance to conceive again.19
An	increased	risk	of	having	one	lifetime	pregnancy	in	women	
with	 CS	 and	 a	 surviving	 child,	 and	 the	markedly	 decreased	 risk	
TA B L E  3  Crude	relative	risks	(RR)	with	95%	confidence	interval	(CI)	for	having	one	lifetime	pregnancy	in	882	803	women	by	preterm	
delivery	(PTD),	small‐for‐gestational‐age	(SGA),	preeclampsia	(PE)	and	cesarean	section	(CS)	with	and	without	a	perinatal	loss	in	first	
pregnancy	(Medical	Birth	Registry	of	Norway,	1967‐2007)	by	10‐year	periods
1967‐1976 RR (95% CI) 1977‐1986 RR (95% CI) 1987‐1996 RR (95% CI) 1997‐2007 RR (95% CI)
PTD	and	no	loss 1.35	(1.30‐1.40) 1.39	(1.34‐1.45) 1.31	(1.26‐1.35) 1.34	(1.29‐1.38)
No	PTD	and	loss 0.48	(0.41‐0.57) 0.37	(0.28‐0.49) 0.49	(0.37‐0.65) 0.54	(0.42‐0.71)
PTD	and	loss 0.71	(0.63‐0.79) 0.63	(0.54‐0.74) 0.61	(0.50‐0.73) 0.66	(0.54‐0.81)
No	PTD	and	no	loss 1.00	(Reference) 1.00	(Reference) 1.00	(Reference) 1.00	(Reference)
SGA	and	no	loss 1.17	(1.14‐1.21) 1.21	(1.18‐1.25) 1.20	(1.16‐1.23) 1.22	(1.18‐1.25)
No	SGA	and	loss 0.62	(0.55‐0.69) 0.52	(0.44‐0.62) 0.52	(0.43‐0.63) 0.63	(0.53‐0.76)
SGA	and	loss 0.64	(0.55‐0.75) 0.58	(0.47‐0.73) 0.67	(0.53‐0.86) 0.57	(0.41‐0.77)
No	SGA	no	loss 1.00	(Reference) 1.00	(Reference) 1.00	(Reference) 1.00	(Reference)
PE	and	no	loss 1.27	(1.22‐1.32) 1.20	(1.16‐1.25) 1.12	(1.08‐1.16) 1.10	(1.06‐1.14)
No	PE	and	loss 0.57	(0.52‐0.63) 0.50	(0.43‐0.59) 0.59	(0.51‐0.69) 0.58	(0.49‐0.69)
PE	and	loss 0.98	(0.79‐1.21) 0.80	(0.51‐1.11) 0.22	(0.09‐0.52) 0.83	(0.54‐1.27)
No	PE	no	loss 1.00	(Reference) 1.00	(Reference) 1.00	(Reference) 1.00	(Reference)
CS and no loss 2.06	(1.98‐2.13) 1.62	(1.58‐1.66) 1.60	(1.56‐1.63) 1.60	(1.55‐1.62)
No	CS	and	loss 0.61	(0.56‐0.67) 0.54	(0.47‐0.63) 0.57	(0.48‐0.68) 0.65	(0.55‐0.77)
CS and loss 1.05	(0.76‐1.45) 0.72	(0.76‐1.45) 0.74	(0.52‐1.06) 0.72	(0.47‐1.08)
No	CS	no	loss 1.00	(Reference) 1.00	(Reference) 1.00	(Reference) 1.00	(Reference)
Women	were	followed	for	the	occurrence	of	a	second	pregnancy	until	2014.
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if	 the	 child	was	 lost,	 suggests	 that	maternal	 choice	 plays	 an	 im-
portant	role.	This	concurs	with	several	previous	studies	that	have	
suggested	voluntary	factors,3,7,16,21	in	contrast	to	the	few	studies	
that	found	no	association	with	reduced	fertility22,23 or concluded 
that	 there	were	obstructive	physical	 consequences	of	CS	on	 fe-
cundity.1,24	It	has	been	suggested	that	an	inverse	cesarean–parity	





creased	 risk	 remained	 irrespective	of	 child	 loss,	 suggesting	 con-
dition severity26	 and/or	 underlying	 health	 factors.	 Similarly,	 in	 a	
Danish	 study,	 increased	 birth	 rate	 after	 death	 of	 a	 child	 in	 ma-
ternal‐requested	CS	but	 only	 a	 slight	 reduction	 for	women	with	













age	of	all	births	 to	 the	 same	mother	and	 study	of	a	 rare	perinatal	
event	 (perinatal	 loss).	 Limitations	 included	 lack	 of	 information	 on	













be	 substantial	 in	 the	MBRN.5	 Validation	 studies	 showed	 good	 as-
certainment	of	pregestational	diabetes	and	PE;14,15	however,	there	
might	be	the	possibility	of	under‐reporting	of	 type	2	diabetes	and	
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Table S1. Adjusted relative risks (RRs) with 95% confidence interval (CI) for one lifetime pregnancy in 882 
803 women by preterm delivery (PTD), small for gestational age (SGA), preeclampsia (PE) and cesarean 
section (CS) with and without perinatal loss in first pregnancy, Medical Birth Registry of Norway 1967 to 
2007. Women were followed for the occurrence of a second pregnancy until 2014. Estimates were adjusted 
for maternal age at first birth, education and year of childbirth and stratified on marital/cohabitating status. 
 
Table S2. Characteristics of 882 803 Norwegian women giving birth to their first child during 1967-2007 by 
10-year periods. Women were followed for the occurrence of a second pregnancy until 2014. Numbers are 
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Table S1. Adjusted relative risks (RRs) with 95% confidence interval (CI) for one lifetime pregnancy in 882 803 
women by preterm delivery (PTD), small for gestational age (SGA), preeclampsia (PE) and cesarean section (CS) 
with and without perinatal loss in first pregnancy, Medical Birth Registry of Norway 1967 to 2007. Women were 
followed for the occurrence of a second pregnancy until 2014. Estimates were adjusted for maternal age at first birth, 
education and year of childbirth and stratified on marital/cohabitating status. 
 
 
Outcomes Married/Cohabitating Unmarried/Single 
PTD and no loss 1.22 (1.20-1.24) 1.11 (1.08-1.14) 
No PTD and loss 0.37 (0.32-0.42) 0.52 (0.43-0.62) 
PTD and loss 0.62 (0.57-0.68) 0.59 (0.52-0.66) 
No PTD no loss  1.00 (Reference) 1.00 (Reference) 
   SGA and no loss 1.13 (1.11-1.15) 1.04 (1.02-1.06) 
No SGA and loss 0.52 (0.47-0.57) 0.55 (0.48-0.62) 
SGA and loss 0.53 (0.47-0.60) 0.58 (0.49-0.69) 
No SGA no loss  1.00 (Reference) 1.00 (Reference) 
   PE and no loss 1.12 (1.10-1.14) 1.04 (1.01-1.07) 
No PE and loss 0.49 (0.46-0.54) 0.55 (0.49-0.61) 
PE and PD 0.69 (0.58-0.82) 0.66 (0.50-0.86) 
No PE no loss  1.00 (Reference) 1.00 (Reference) 
   CS and no loss 1.29 (1.27-1.31) 1.07 (1.04-1.09) 
No CS and loss 0.52 (0.48-0.56) 0.56 80.51-0.63) 
CS and loss 0.70 (0.58-0.85) 0.54 (0.38-0.77) 
No CS no loss  1.00 (Reference) 1.00 (Reference) 
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Appendix I. Notification form, the Medical Birth Registry of  
 Norway, 1967-1998    
 
  
  Appendix II. Notification form, the Medical Birth Registry of  
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Page XI, under II):  Missing words: “Lipid levels after childbirth and association with 
number of children” – corrected to “Lipid levels after childbirth and association with 
number of children: A population-based cohort study”. 
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